Form 8-K
8-K — OMEGA HEALTHCARE INVESTORS INC
Accession: 0001104659-26-065158
Filed: 2026-05-21
Period: 2026-05-19
CIK: 0000888491
SIC: 6798 (REAL ESTATE INVESTMENT TRUSTS)
Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — tm2615007d1_8k.htm (Primary)
EX-10.1 — EXHIBIT 10.1 (tm2615007d1_ex10-1.htm)
EX-10.2 — EXHIBIT 10.2 (tm2615007d1_ex10-2.htm)
EX-10.3 — EXHIBIT 10.3 (tm2615007d1_ex10-3.htm)
EX-10.4 — EXHIBIT 10.4 (tm2615007d1_ex10-4.htm)
EX-99.1 — EXHIBIT 99.1 (tm2615007d1_ex99-1.htm)
GRAPHIC (tm2615007d1_ex99-1img001.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: tm2615007d1_8k.htm · Sequence: 1
false
0000888491
0000888491
2026-05-19
2026-05-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 19, 2026
OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in
its charter)
Maryland
1-11316
38-3041398
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
303 International Circle,
Suite 200
Hunt Valley, Maryland 21030
(Address of principal executive offices
/ Zip Code)
(410) 427-1700
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act.
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section
12(b) of the Securities Exchange Act of 1934:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.10 par value
OHI
New York Stock Exchange
Item 5.02 Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
CEO and CFO Leadership Transitions
On May 19, 2026, the Board of Directors
(the “Board”) of Omega Healthcare Investors, Inc. (the “Company”) approved senior leadership transitions
reflecting upcoming retirement plans and the Company’s long-term leadership succession planning. On May 19, 2026, the Board and
C. Taylor Pickett, the Company’s Chief Executive Officer, mutually agreed that Mr. Pickett’s employment with the Company
and position as a member of the Board will terminate effective October 1, 2026 (the “CEO Transition Date”). The Board also
appointed Matthew P. Gourmand, the Company’s President, to serve as the Company’s President and Chief Executive Officer, effective
as of the CEO Transition Date.
In addition, on May 19, 2026, the Board
and Robert O. Stephenson mutually agreed that Mr. Stephenson’s employment with the Company will terminate effective August 1, 2026
(the “CFO Transition Date”). The Board also appointed Neal A. Ballew, the Company’s Senior Vice President and Chief
Accounting Officer, to serve as the Company’s Chief Financial Officer, and Lucas M. Golem, the Company’s Vice President of
Financial Reporting, to succeed Mr. Ballew’s position and serve as the Company’s Chief Accounting Officer, both effective
as of the CFO Transition Date.
Mr. Gourmand (age 51) has served as
the Company’s President since January 1, 2025. Prior to that, Mr. Gourmand had served as the Company’s Senior Vice President
of Corporate Strategy & Investor Relations since October 2017. Prior to joining the Company, Mr. Gourmand spent ten
years as an equity portfolio manager at Millennium Partners and Stevens Capital Management, three years as an equity research analyst
at UBS and six years in the audit department of Deloitte, where he qualified as a Chartered Accountant and a Certified Public Accountant.
He earned an LLB in Law from University College, London, and holds the Chartered Financial Analyst designation.
Mr. Ballew (age 40) has served as
the Company’s Senior Vice President and Chief Accounting Officer since August 2020. Prior to joining the Company, from September
2010 until August 2020, Mr. Ballew served in the real estate and hospitality audit practice of Ernst & Young, LLP (“EY”),
most recently as senior manager within EY’s professional practice group, where he assisted audit clients on technical accounting
matters. Mr. Ballew earned a Bachelor of Science and Master of Accountancy from the Marriott School of Management at Brigham Young University.
Mr. Ballew is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants.
Mr. Golem (age 41) has served as the
Company’s Vice President of Financial Reporting since October 2024, previously serving as the Company’s Senior Director of
Financial Reporting from May 2021 to October 2024. Prior to joining the Company, Mr. Golem served in financial accounting and financial
reporting roles at Algeco Scotsman Group (July 2013 to December 2017) and, following its North American spin-off, at WillScot Holdings
Corporation (Nasdaq: WSC) (January 2018 to May 2021), most recently as Senior Director of Accounting at WillScot. Prior to that, Mr. Golem
served as an audit manager at Deloitte. Mr. Golem earned a Bachelor of Business Administration in Accounting from Loyola University Maryland.
Mr. Golem is a Certified Public Accountant.
None of Mr. Gourmand, Mr. Ballew or
Mr. Golem have any family relationship with any director, executive officer or person chosen to become a director or executive officer
of the Company, nor are there any arrangements or understandings between any of Mr. Gourmand, Mr. Ballew or Mr. Golem and any
other person(s) pursuant to which they were selected to become an officer or director of the Company. There are no related party
transactions between any of Mr. Gourmand, Mr. Ballew or Mr. Golem and the Company reportable under Item 5.02 of Form 8-K
and Item 404(a) of Regulation S-K. Messrs. Gourmand, Ballew and Golem’s employment agreements will be amended as of the respective
transition dates to reflect their new roles.
Transition and Consulting Agreements
In connection with Mr. Pickett’s
departure and the transitioning of his responsibilities, the Company and its subsidiary OHI Asset Management LLC (“Omega Asset Management”)
entered into a Transition Agreement and Release with Mr. Pickett effective as of May 19, 2026 (the “Pickett Transition Agreement”).
The Pickett Transition Agreement provides that Mr. Pickett will be entitled to receive the annual short-term incentive actually earned
for 2026 on an un-prorated basis, his previously granted equity incentives will vest through December 31, 2029 on an un-prorated basis
but otherwise subject to the terms of such awards, and he will be entitled to employer-paid group health insurance premiums pursuant to
COBRA coverage for up to 18 months following the CEO Transition Date. The Pickett Transition Agreement also provides that the Company
will cause ownership of Mr. Pickett’s supplemental life insurance policy to be transferred to him as of the CEO Transition Date.
Additionally, pursuant to a Consulting
Agreement entered into between the Company and Mr. Pickett dated as of May 19, 2026 and effective as of October 2, 2026 (the “Pickett
Consulting Agreement”), Mr. Pickett will perform such consulting and advisory services as the Company may require in connection
with transitioning his responsibilities through October 1, 2027, subject to extension at the Company’s option through April 1, 2028,
in exchange for a consulting fee of $20,000 per month. All separation and other benefits described herein are conditioned on Mr. Pickett
executing a general release of claims against the Company as well as his continued compliance with the Pickett Transition Agreement, the
Pickett Consulting Agreement and all applicable post-termination employee covenants.
In connection with Mr. Stephenson’s
departure and the transitioning of his responsibilities, the Company and Omega Asset Management entered into a Transition Agreement and
Release with Mr. Stephenson effective as of May 19, 2026 (the “Stephenson Transition Agreement”). The Stephenson
Transition Agreement provides that Mr. Stephenson will be entitled to receive the payments and benefits due in connection with a
termination of employment by the Company without cause pursuant to his Employment Agreement effective January 1, 2026, as amended,
provided that he will also be entitled to the annual short-term incentive actually earned for 2026 on an un-prorated basis, and his previously
granted equity incentives will vest through December 31, 2029 on an un-prorated basis but otherwise subject to the terms of such awards.
The Stephenson Transition Agreement also provides that the Company will cause ownership of Mr. Stephenson’s supplemental life insurance
policy to be transferred to him as of the CFO Transition Date.
Additionally, pursuant to a Consulting
Agreement entered into between the Company and Mr. Stephenson dated as of May 19, 2026 and effective as of August 2, 2026 (the “Stephenson
Consulting Agreement”), Mr. Stephenson will perform such consulting and advisory services as the Company may require in connection
with transitioning Mr. Stephenson’s responsibilities through August 1, 2027, subject to extension at the Company’s option
through February 1, 2028, in exchange for a consulting fee of $12,000 per month. All separation and other benefits described herein are
conditioned on Mr. Stephenson executing a general release of claims against the Company, as well as his continued compliance with the
Stephenson Transition Agreement, the Stephenson Consulting Agreement and all applicable post-termination employee covenants.
The descriptions of the Pickett Transition
Agreement, the Pickett Consulting Agreement, the Stephenson Transition Agreement and the Stephenson Consulting Agreement contained in
this Current Report on Form 8-K do not purport to be complete and are qualified in their entirety by reference to the Pickett Transition
Agreement, the Pickett Consulting Agreement, the Stephenson Transition Agreement and the Stephenson Consulting Agreement, respectively,
copies of which are filed herewith as Exhibits 10.1, 10.2, 10.3 and 10.4, respectively, and are incorporated in this Item 5.02 by reference.
Item 7.01 Regulation FD Disclosure
On May 21, 2026, the Company issued a press release announcing the
executive transitions described above. The press release, furnished as Exhibit 99.1 hereto, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No.
Description of Exhibit
10.1
Transition Agreement and Release, dated as of May 19, 2026, among Omega Healthcare Investors, Inc., OHI Asset Management LLC and Mr. Pickett.
10.2
Consulting Agreement, dated as of May 19, 2026, and effective as of October 2, 2026, between Omega Healthcare Investors, Inc. and Mr. Pickett.
10.3
Transition Agreement and Release, dated as of May 19, 2026, among Omega Healthcare Investors, Inc., OHI Asset Management LLC and Mr. Stephenson.
10.4
Consulting Agreement, dated as of May 19, 2026, and effective as of August 2, 2026, between Omega Healthcare Investors, Inc. and Mr. Stephenson.
99.1
Press release issued by the Company on May 21, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
OMEGA HEALTHCARE INVESTORS, INC.
Dated: May 21, 2026
By:
/s/ Gail D. Makode
Gail D. Makode
Chief Legal Officer, General Counsel
EX-10.1 — EXHIBIT 10.1
EX-10.1
Filename: tm2615007d1_ex10-1.htm · Sequence: 2
Exhibit 10.1
Execution Version
TRANSITION AGREEMENT AND RELEASE
THIS TRANSITION AGREEMENT
AND RELEASE (the “Agreement”) is made effective as of May 19, 2026 (the “Effective Date”), except
as otherwise provided herein, among Omega Healthcare Investors, Inc. (“Parent”), Omega Asset Management LLC (the “Company”)
and C. Taylor Pickett (“Executive”). The Parent, the Company and the Executive, when collectively referred to, are
hereinafter identified as the “Parties”.
INTRODUCTION
Effective October 1, 2026
(the “Transition Effective Date”), Executive will terminate employment from, and cease to hold any positions with,
the Company and its “Affiliates,” which shall mean, for purposes of this Agreement, any person, firm, corporation,
partnership, association or entity that, directly or indirectly or through one or more intermediaries, controls, is controlled by or is
under common control with the Company, as determined by the Company; and the term of the Employment Agreement effective January 1, 2026
as amended, among Parent, the Company and Executive (the “Employment Agreement”) is hereby terminated as of October
1, 2026. In addition, effective as of October 2, 2026, Parent and Executive shall enter into a Consulting Agreement (the “Consulting
Agreement”), substantially in the form attached as Exhibit A hereto, pursuant to which Executive shall perform business
consulting and business advisory services to Parent and its Affiliates from and after October 2, 2026 through October 1, 2027 (the “Initial
Consulting Term”), subject to extension at Parent’s option through April 1, 2028 (the “Extended Consulting
Term”, with the Initial Consulting Term and, if extended, the Extended Consulting Term, being referred to as the “Consulting
Term”). Pursuant to the Employment Agreement, Executive’s termination of employment on October 1, 2026, constitutes a
voluntary termination by Executive. Further, the Company recognizes that due in part to Executive’s long tenure with the Company
and its Affiliates, Executive has unique knowledge, experience and skills, and the Company has a unique need to engage Executive for an
interim period to assist in a smooth transition of his duties and knowledge to other officers. Accordingly, the Parties desire to enter
into this Agreement pursuant to which Executive agrees to continue to be employed until the Transition Effective Date, will be entitled
to certain other incentive compensation and agrees to provide transitional consulting services to the Company during the Consulting Term,
in each case upon the terms set forth below.
NOW, THEREFORE, the Parties
agree as follows:
1.
Terms and Conditions of Engagement.
(a) Transitional
Employment and Consulting Agreement. The Company and Executive agree that Executive shall remain employed by the Company until the
Transition Effective Date, and Parent and Executive shall enter into the Consulting Agreement effective October 2, 2026, pursuant to which
Executive shall perform such business consulting and business advisory services to Parent and its Affiliates as Parent may require from
time to time during the Consulting Term.
2.
Compensation.
The Parties hereby agree that,
in consideration for Executive’s promises contained herein, the Executive shall remain employed in his current role and be paid
his base salary at his current rate through and until the Transition Effective Date, as well as continue participation in any Company
benefit plans through and until the Transition Effective Date. Further, in consideration for Executive’s promises contained herein,
and provided that Executive executes this Agreement and returns it to the Company by the Effective Date, executes and returns to the Company
the Release Agreement described in Section 2(e) hereof on the first business day after the Transition Effective Date, and does not challenge
any portion of this Agreement, including the Release Agreement, or revoke the Release Agreement within the revocation period provided
therein, and provided that Executive complies with this Agreement, the Employment Agreement, the Parent’s Code of Business Conduct
and Ethics (which the Parties agree, shall for all purposes of this Agreement continue to apply to the Executive in his capacity as a
consultant pursuant to the Consulting Agreement to the same extent as if he continued to be an officer of the Parent), the Consulting
Agreement and the Intellectual Property Agreement (as defined below), Executive shall be entitled to receive the following amounts (collectively
referred to herein as the “Transition Amounts”), in addition to any consulting fees payable pursuant to the Consulting
Agreement:
(a)
Benefits. Following the Transition Effective Date, should Executive elect to receive benefits through COBRA,
Executive shall be entitled to payment of 100% of the applicable monthly COBRA premium under the Company’s group health plan
for the coverage elected by Executive, his spouse and his eligible dependents, continued for the lesser of eighteen (18) month or until
such COBRA coverage for Executive (or his spouse or dependents) terminates, which the Company shall pay directly to its group health plan
insurer on Executive’s behalf, provided however, that if such payment would violate applicable law or result in liability or penalties
under applicable law, the Company shall instead pay Executive a taxable amount equal to the amount of each such monthly premium, with
each monthly premium amount being paid in at least monthly installments until all such required taxable amounts have been paid. In addition,
the Company shall cooperate with Employee to cause Employee’s supplemental life insurance policy to remain in effect following Employee’s
termination of employment and to cause the transfer of any and all benefits under such policy to Employee as of such time, in each case
subject to the consent and requirements of the respective insurance carrier and the terms of such insurance policy, and provided that
Employee assumes the full responsibility for any premiums owing under such policy following the Transition Effective Date and any tax
liability associated the transfer of such policy benefits to Employee.
(b)
2026 Short-Term Incentive. The Company shall pay Executive the short-term incentive that is earned based on performance
for 2026, determined without proration for the fact that the Executive’s Separation from Service will occur before the end of 2026
and without regard to the fact that the Executive will not be an employee of the Company on the date that such short-term incentive is
paid. This amount will be payable on the same date that the short-term incentives for 2026 performance are payable to the executive officers
of the Company.
(c)
Equity Awards. Executive shall be entitled to any rights to and amounts due under any unvested and outstanding equity awards
made by Parent or any of its Affiliates to Executive, as specified according to the terms and conditions of such awards or grants or pursuant
to any plans or documents otherwise governing such awards or grants, provided that, if Executive executes and returns this Agreement,
complies with the Consulting Agreement and does not terminate the Consulting Agreement before the end of the Consulting Term and the Company
does not terminate the Consulting Agreement before the end of the Consulting Term due to breach by Executive, such awards shall vest to
the same extent as if Executive provided services through the date required for 100% vesting. The Parties agree that the proviso in the
prior sentence replaces and supersedes and extinguishes any vesting terms that require proration of units otherwise provided for in the
applicable terms and conditions of such awards or grants or pursuant to any plans, documents or policies otherwise governing such awards
or grants. For the avoidance of doubt, the amounts of all such outstanding equity awards due to Executive hereunder are limited to the
amounts specified below, but otherwise remain subject to all the terms and conditions of such equity awards:
2
(i) Time-Based Awards. Subject to Sections 2(e), (f) and (g), 3, 4 and 5, Executive shall vest a total
of 188,364 time-based profits interest units under the Time-Based Profits Interest Units Award Agreements issued by Parent effective January 1,
2024, January 1, 2025 and January 1, 2026 on the same dates as if he continued to be employed through December 31, 2028. The 188,364 units
are comprised of 71,105 units under the January 1, 2024 award agreement, 59,928 units under the January 1, 2025 award agreement and 57,331
units under the January 1, 2026 award agreement.
(ii) Performance-Based Awards. Subject to Sections 2(e), (f) and (g), 3, 4, and 5, Executive shall vest
in the same number of performance profits interest units under the agreements below on the same dates as if he continued to be employed
through December 31, 2029. The number of units, in the case of the January 1, 2023 grants, is the actual number of units earned as set
forth below (which includes the number already quarterly vested in 2026), and in the case of the January 1, 2024, January 1, 2025, and
January 1, 2026 grants, the number of units will be based on the applicable level of performance achieved (below threshold (in which case
nothing will vest), threshold, target or high) and are based on an assumption that a “Change in Control” (as defined in such
agreements) does not occur during the applicable “Performance Period” (as defined in such agreements). If a Change in Control
does occur during the applicable Performance Period, the number of vested units will be determined under the applicable agreement, as
modified by this subsection.
Agreement
Performance-Based
Units
Actual Number
Earned
1/1/2023
for 12/31/2025 Performance Period end
-TSR-Based Performance Profit Interests
Units Award Agreement
276,902
-Relative TSR-Based Performance Profit
Interests Units Award Agreement
104,708
Threshold
Target
High
1/1/2024
for 12/31/2026 Performance Period end
-TSR-Based Profits Interests Units
Award Agreement
17,672
111,086
320,958
- Relative TSR-Based Performance Profit
Interests Units Award Agreement
16,359
107,248
329,804
1/1/2025
for 12/31/2027
Performance Period end
-TSR-Based Performance Profit Interests
Units Award Agreement
15,357
96,992
282,696
-Relative TSR-Based Performance Profit
Interests Units Award Agreement
12,534
81,303
246,322
1/1/2026
for 12/31/2028 Performance Period end
-TSR-Based Performance Profit Interests
Units Award Agreement
15,271
97,582
289,756
-Relative TSR-Based Performance Profit
Interests Units Award Agreement
11,442
74,846
230,829
3
(d)
Expenses. Executive shall be entitled to be reimbursed in accordance with Company policy for
reasonable and necessary expenses incurred by Executive in connection with the performance of Executive’s duties of employment hereunder
through the Transition Effective Date in accordance with the Employment Agreement.
(e)
Release Contingency. The payments to Executive required by Sections 2(a) through 2(c) are contingent upon Executive executing
the Release Agreement attached hereto as Exhibit B (the “Release Agreement”) on, and delivering it to the Company,
on the first business day after the Transition Effective Date and not revoking the Release Agreement in accordance with its procedures
within the revocation period provided in the Release Agreement. If Executive fails to timely execute and deliver the Release Agreement
or if Executive revokes the Release Agreement within the revocation period provided in the Release Agreement, this Agreement shall thereupon
automatically terminate, without the requirement of any further action by any party, provided that the provisions of Sections 4 and 5
hereof shall continue to apply to Executive.
(f)
Section 409(a). All payments provided for in this Agreement are intended to be exempt from Section 409A of the Internal
Revenue Code (“Code Section 409A”) to the maximum extent possible, and any payments that are subject to Code Section
409A are intended to be compliant therewith, and this Agreement shall be construed consistent with such intent. For purposes of Code Section
409A, each the entitlement to a series of installment payments hereunder will be treated as the right to a series of separate payments
to the extent not inconsistent with any other agreement to which Executive is subject. Notwithstanding any other provision hereof if the
Executive is a “specified employee” within the meaning of Code Section 409A at the date of his separation from service, then
if, and solely to the ex\tent, required to avoid a tax under Code Section 409A, payments which would otherwise have been made during the
first six (6) months after separation from service shall be withheld and paid to the Executive during the seventh month following the
date of his termination of employment. While the Company intends that no payment under this Agreement shall be subject to tax under Code
Section 409A, the Company provides no guarantee of tax consequences to Executive and Executive shall be responsible for Executive’s
own taxes. Notwithstanding the foregoing, if the total payments to be paid to Executive hereunder, along with any other payments to Executive,
would result in Executive being subject to the excise tax imposed by Code Section 4999, the Company shall reduce the aggregate payments
to the largest amount which can be paid to Executive without triggering the excise tax, but only if and to the extent that such reduction
would result in Executive retaining larger aggregate after-tax payments. The determination of the excise tax and the aggregate after-tax
payments to be received by Executive will be made by the Company after consultation with its advisors and in material compliance with
applicable law. If payments are to be reduced, to the extent permissible under Code Section 4999, payments will be reduced in a manner
that maximizes the after-tax economic benefit to Executive and to the extent consistent with that objective, in the following order of
precedence: (A) first, payments will be reduced in order of those with the highest ratio of value for purposes of the calculation of the
parachute payment to projected actual taxable compensation to those with the lowest such ratio, (B) second, cash payments will be reduced
before non-cash payments, and (C) third, payments to be made latest in time will be reduced first. Any reduction will be made in a manner
that is intended to avoid a tax being incurred under Code Section 409A.
4
(g)
Incentive Recovery Policy. Pursuant to Section 8 of the Employment Agreement, Executive has agreed to be bound by the Company’s
Incentive Compensation Recovery Policy, as amended, and that this provision shall survive termination of the Employment Agreement and
this Agreement.
(h)
Death or Disability. If Executive dies or becomes subject to a “Disability” (as defined in the Employment Agreement)
after the Effective Date while employed by the Company or while he is a consultant during the Consulting Term and was otherwise in full
compliance with all of the provisions of this Agreement through his date of death or Disability, the payments and benefits provided for
herein shall accrue and be paid to Executive or the legal representative of Executive’s estate in the case of death, other than
any unearned fees pursuant to the terms of the Consulting Agreement, and in addition, the vesting of the profits interest units described
in Section 2(c) shall be accelerated to the date of death or Disability, or in the case of the performance-based profits interest units,
the last day of the applicable Performance Period(s) if later than the date of death or Disability.
3.
Termination.
(a) Termination.
This Agreement may be terminated only: (i) by mutual agreement of the Parties; (ii) as provided in Section 2, as a result of the failure
of Executive to timely execute and deliver the Release Agreement or as a result of Executive revoking the Release Agreement; or (iii)
by the Company, as a result of Executive’s material breach of this Agreement, the Employment Agreement, the Parent’s Code
of Business Conduct and Ethics, the Consulting Agreement or the Intellectual Property Agreement (only if the Company has first given Executive
written notice of the breach and a reasonable opportunity to cure the same) or as a result of the Company terminating Executive’s
employment for “Cause” (as defined in the Employment Agreement) pursuant to the provisions of the Employment Agreement. Notice
of termination shall be given prior to termination in writing and shall specify the effective date of termination. Except for earned and
accrued salary and benefits and expenses under Sections 2 and 2(d), Executive shall not be entitled to any payments or vesting provided
for in Section 2 if this Agreement is terminated under clauses (ii) or (iii) above.
(b) Survival.
The covenants of Executive in Sections 4 and 5 hereof and shall survive the termination of this Agreement and shall not be extinguished
thereby.
5
4.
Restrictive Covenants.
(a)
Executive previously agreed pursuant to Sections 4, 5, 6 and 8 of the Employment Agreement to be subject to certain nondisclosure,
cooperation, noncompetition, nonsolicitation and nondisparagement obligations, as well as the Company’s Incentive Compensation Recovery
Policy, as amended, and the Intellectual Property Agreement between Company and the Executive dated as of August 28, 2024 (the “Intellectual
Property Agreement”), each of which survived his termination of employment. Executive confirms that he agrees to comply with
his obligations pursuant to Sections 4, 5, 6 and 8 of the Employment Agreement and that Executive’s compliance with the same shall
be a condition of his receiving the amounts and benefits provided for under Sections 2(a) through 2(c) hereof.
(b)
The Employment Agreement is hereby amended effective as of the Transition Effective Date to add the following to the end of Section
11(d): “Notwithstanding the foregoing, neither Saber Healthcare Group, LLC, nor any of its subsidiaries as to which Saber Healthcare
Group, LLC owns equity securities representing more than 50% of the ordinary voting power, shall be deemed to be a Competing Business.”
5.
Remedies and Enforceability.
Executive agrees that the
covenants, agreements, and representations contained in Section 4 hereof are of the essence of this Agreement; that each of such covenants
are reasonable and necessary to protect and preserve the interests and properties of the Company and its Affiliates; that irreparable
loss and damage will be suffered by the Company and its Affiliates should Executive breach any of such covenants and agreements; that
each of such covenants and agreements is separate, distinct and severable not only from the other of such covenants and agreements but
also from the other and remaining provisions of this Agreement; that the unenforceability of any such covenant or agreement shall not
affect the validity or enforceability of any other such covenant or agreements or any other provision or provisions of this Agreement;
and that if Executive materially breaches a covenant in Section 4 hereof or materially breaches this Agreement, the Employment Agreement,
the Intellectual Property Agreement or the Consulting Agreement, (a) Executive shall forfeit all compensation under Sections 2(a) through
2(c), including compensation that has already been paid and compensation that has already vested, and Executive shall immediately upon
the Company’s demand repay all such compensation as has already been paid, and (b) the Company and Parent shall be entitled to seek
both temporary and permanent injunctions to prevent a breach or contemplated breach by Executive of any of such covenants or agreements,
in addition to other remedies available to them.
6
6.
Notice.
All notices, requests, demands
and other communications required hereunder shall be in writing and shall be deemed to have been duly given if delivered or if mailed,
by United States certified or registered mail, prepaid to the party to which the same is directed at the following addresses (or at such
other addresses as shall be given in writing by the Parties to one another):
If to the Company:
Omega Healthcare Investors, Inc.
303 International Circle, Suite 200
Hunt Valley, MD 21030
Attn: Chief Legal Officer, General Counsel
If to Executive:
to the last address the Company
has on file for Executive
Notices delivered in person shall be effective on
the date of delivery. Notices delivered by mail as aforesaid shall be effective upon the fourth calendar day subsequent to the postmark
date thereof.
7.
Miscellaneous.
(a) Assignment.
The rights and obligations of the Company and Parent under this Agreement shall ensure the benefit of the Company’s and Parent’s
successors and assigns. This Agreement may be assigned by the Company or Parent to any legal successor to the Company’s or Parent’s
business or to an entity that purchases all or substantially all of the assets of the Company or Parent, but not otherwise without the
prior written consent of Executive. Executive may not assign this Agreement.
(b) Tax
Withholding. All payments hereunder shall be reduced by applicable tax withholding and all other lawful deductions.
(c) Waiver.
The waiver of any breach of this Agreement by any party shall not be effective unless in writing, and no such waiver shall constitute
the waiver of the same or another breach on a subsequent occasion.
(d) Governing
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The Parties
agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy arising
under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The Parties consent
to the jurisdiction of such courts.
(e) Entire
Agreement. This Agreement embodies the entire agreement of the Parties hereto relating to the subject matter hereof and supersedes
all oral agreements, and to the extent inconsistent with the terms hereof, all other written agreements. The Parties agree that the term
of the Employment Agreement is terminated effective on the Transition Effective Date and that the Employment Agreement is hereby terminated
on the Transition Effective Date, except as to the terms which survive termination, including without limitation Sections 4 and 5 of the
Employment Agreement. As of the Transition Effective Date, Executive resigns from all positions that he holds with Parent (including without
limitation as a member of Parent’s Board of Directors), the Company and the Affiliates.
(f) Amendment.
This Agreement may not be modified, amended, supplemented or terminated except by a written instrument executed by the Parties hereto.
7
(g) Severability.
Each of the covenants and agreements hereinabove contained shall be deemed separate, severable and independent covenants, and in the event
that any covenant shall be declared invalid by any court of competent jurisdiction, such invalidity shall not in any manner affect or
impair the validity or enforceability of any other part or provision of such covenant or of any other covenant contained herein.
(h) Captions
and Section Headings. Captions and section headings used herein are for convenience only and are not a part of this Agreement and
shall not be used in construing it.
8
IN WITNESS WHEREOF,
Parent, the Company and Executive have each executed and delivered this Agreement as of the date first shown above.
OMEGA HEALTHCARE INVESTORS, INC.
By:
/s/
Gail D. Makode
Gail D. Makode, Chief Legal Officer
OHI ASSET MANAGEMENT LLC
By:
/s/ Gail D. Makode
Gail D. Makode, Chief Legal Officer
EXECUTIVE
By:
/s/ C. Taylor
Pickett
C. Taylor Pickett
9
EXHIBIT A
CONSULTING AGREEMENT
Exhibit A
CONSULTING AGREEMENT
This Consulting Agreement
(this “Agreement”) is entered as of May 19, 2026 to be effective as of October 2, 2026, by and between Omega
Healthcare Investors, Inc. (hereinafter “Omega” or the “Company”) and C. Taylor Pickett (hereinafter
“Consultant”).
RECITALS
WHEREAS, until October
1, 2026, Consultant was an officer and director of Omega, as well as an officer and director of subsidiaries of Omega (collectively, the
“Omega Companies”);
WHEREAS, Consultant
has expertise in the area of Omega’s business and is willing to provide consulting services to Omega as set forth herein; and
WHEREAS, Omega is
willing and desires to engage Consultant as an independent contractor, during the Term (as defined below), on the terms and conditions
set forth herein.
NOW, THEREFORE, in
consideration of the foregoing and of the mutual promises set forth herein, and intending to be legally bound, the parties hereto agree
as follows:
AGREEMENT
1.
Term; Termination; Rights on Termination.
(a)
This Agreement will commence on October 2, 2026,
and unless modified by the mutual written agreement of the parties, shall continue until and through October 1, 2027 (as it may be extended,
the “Term”), which shall be subject to extension by the Company (exercisable in the Company’s sole discretion)
until and through April 1, 2028 to the extent the Company provides written notice to the Executive on or before October 1, 2027.
This Agreement may be terminated at any time, with or without cause, by either party with ten (10) days written notice to the other
party, and will also terminate if Consultant dies during the Term. The effectiveness of this Agreement is contingent upon Consultant signing
on October 2, 2026, and returning on October 2, 2026 that certain Release Agreement and not revoking the Release Agreement within the
revocation period provided therein.
(b)
If Omega terminates this Agreement during the Term, other than for Consultant’s willful failure or gross negligence in performing the consulting services described on Schedule A hereof (the “Services”) or due to a material breach of that certain Transition and Release Agreement dated May 19, 2026 (the “Transition Agreement”) or another agreement described therein, Consultant shall receive from Omega, the monthly Consulting Fee (defined below) then in effect for whatever time period is remaining under the Term. If Omega terminates this Agreement due to Consultant’s willful failure or gross negligence in performing the Services or due to a material breach of the Transition Agreement or another agreement described therein or Consultant terminates this Agreement during the Term or dies during the Term, the Company shall pay Consultant only so much of the monthly Consulting Fee as have accrued to the date of termination of this Agreement.
Exhibit A - Page 1
2.
Compensation.
In consideration of the Services that may be performed by Consultant, Omega agrees to pay Consultant $20,000 per month during the Term as a retainer for Consultant’s services for Services of up to twenty (20) hours per month, subject to the maximum number of hours of services to be provided as described in Section 3(b) below, with monthly payments being made on or before the last business day of the month following provision of the Services during the Term of this Agreement (“Consulting Fee”). Should Consultant exceed 20 hours per month in provision of the Services, the Chief Executive Officer and Consultant shall mutually agree on any additional fee payable, if any. The Company may withhold from any amounts payable with respect to this Agreement such federal, state, local and other taxes as may be required to be withheld, if any, pursuant to any applicable law or regulation. As Consultant is not an employee of any of the Omega Companies, Consultant shall not be permitted to participate in any benefit plans of any of the Omega Companies, except for any right he has to participate in group health plans pursuant to COBRA as a result of a termination of employment.
3.
Terms and Scope of Services.
(a)
This Agreement shall control and govern all work performed by Consultant. No subsequent variance from, amendment to or modification of this Agreement shall be binding upon the Omega Companies unless it is in writing, expressly provides that it is intended as a variance, amendment or modification and is executed by a fully authorized representative of the Omega Companies.
(b)
The scope of services to be provided hereunder is set forth in Schedule A hereto and as further modified and amended under subsequent written agreements between the parties.
(c)
All travel and out-of-pocket expenses incurred by Consultant for the benefit of the Omega Companies and in the performance of this agreement that are approved by the Company, shall be reimbursed by the Company within ten (10) business days following presentation of valid expense receipts.
(d)
All payments to Consultant hereunder will be reported on Form 1099, and Consultant agrees to accept exclusive liability for the payment of all taxes, contributions for unemployment insurance, old age and survivor’s insurance or annuities, which are based on the fees and expense reimbursements paid to Consultant; and Consultant agrees to reimburse Omega for any of the aforesaid taxes or contributions which by law Omega may be required to pay because of Consultant’s failure to pay the same.
(e)
Consultant acknowledges that the Company makes no warranties as to any tax consequences regarding payment of the Consulting Fee, and Consultant shall solely be responsible for payment of his own taxes.
Exhibit A - Page 2
(f)
Consultant, as an independent contractor, shall personally perform the services rendered under this Agreement and may not subcontract or delegate his duties to any other party. It is specifically understood and agreed that the manner and means of performing the services required under this Agreement shall be at the sole discretion of the Consultant through use of his independent judgment. Subject to Section 3(b), Consultant shall devote sufficient business time and efforts to the performance of services for the Company to complete the services within the time frames for completion established by the Company. Consultant shall use Consultant’s best efforts in such endeavors. Consultant shall also perform Consultant’s services with a level of care, skill, and diligence that a prudent professional acting in a like capacity and familiar with such matters would use.
(g)
Consultant shall have no authority to bind the
Omega Companies or any of its officers or employees to any agreement or to make managerial or Consultant decisions that are binding on
the Omega Companies. Consultant shall not be subject to the supervision, direction or control of the Omega Companies as to the particular
means or methods of performing his services. However, the Omega Companies shall retain the right to review and inspect at any time any
part of the work performed by Consultant to assure compliance with appropriate standards and specifications.
(h)
Upon request or when Consultant’s relationship with the Company terminates, Consultant will immediately deliver to the Company all copies of any and all materials and writings received from, created for, or belonging to the Company including, but not limited to, those which relate to or contain proprietary or confidential information, consistent with the requirements of the Intellectual Property Agreement.
4.
Indemnification. The Company will indemnify Consultant for expenses actually and reasonably incurred that directly result from any claims made against Consultant arising out of any actions by Consultant that are within the scope of services, and consistent with the standards of performance, required under this Agreement, except to the extent that the Consultant’s actions were dishonest, were in bad faith, were opposed to the interests of the Company, involved an improper personal benefit to Consultant, involved criminal conduct by Consultant or were grossly negligent; provided, however, as a condition of indemnification, Consultant must promptly notify the Company of each claim that may give rise to indemnification hereunder and all relevant facts of which Consultant is aware and, unless the Company has a conflict of interest, the Consultant must allow the Company to assume the defense of the claim.
5.
Entire Agreement. This Agreement contains
the entire understanding and agreement between the parties hereto with respect to its subject matter and supersedes any prior or contemporaneous
written or oral agreements, representations or warranties between them respecting the subject matter hereof, other than the Transition
and Release Agreement entered into between Consultant and Omega.
6.
Amendment. This Agreement may be amended only by a writing signed by Consultant and by a duly authorized officer of Omega.
Exhibit A - Page 3
7.
Remedy for Breach. Should either Consultant or Omega resort to legal proceedings to enforce this Agreement, the prevailing party in such legal proceeding shall be awarded, in addition to such other relief as may be granted, attorneys’ fees and costs incurred in connection with such proceeding.
8.
Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The parties agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy arising under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The parties consent to the jurisdiction of such courts.
9.
Duplicate. This Agreement may be executed
in duplicate originals and is not effective unless signed by both parties.
IN WITNESS WHEREOF,
Omega and Consultant have executed this Agreement effective as of the date first written above.
Consultant
Omega Healthcare Investors, Inc.
By:
By
C. Taylor Pickett
Gail D. Makode,
Chief Legal Officer
Exhibit A - Page 4
SCHEDULE A
SCOPE OF SERVICES
Consultant shall render such transitional support
services and perform such individual projects as may be requested by the Chief Executive Officer or the Board of Directors of Omega from
time to time during the Term (the “Services”).
Exhibit A – Schedule A
EXHIBIT B
RELEASE AGREEMENT
Exhibit B
RELEASE AGREEMENT
This Agreement (this “Agreement”)
is made October 2, 2026, among Omega Healthcare Investors, Inc. (“Parent”), OHI Asset Management LLC (“Employer”),
and C. Taylor Pickett (“Employee”).
Introduction
On October 1, 2026, Employee
ceased to be employed as an employee of the Company and an executive officer of Parent and the Company as provided in that certain Transition
and Release Agreement dated May 19, 2026 (the “Transition and Release Agreement”). Effective October 2, 2026, Employer,
Parent and Employee entered into a Consulting Agreement (the “Consulting Agreement”).
The Transition and Release
Agreement requires that as a condition to Employee’s right to receive payments and vesting under Sections 2(a) through 2(c) thereunder
(the “Transition Amounts”) and as a condition to the effectiveness of the Consulting Agreement, Employee must execute
this Agreement.
NOW, THEREFORE, the
parties agree as follows:
1. Employee has been offered at least twenty-one (21) days from receipt of this Agreement within which to
consider this Agreement, and to become effective this Agreement must be signed by Employee on (and not before or after) October 2, 2026,
and returned to Employer on that same date. The effective date of this Agreement shall be the date eight (8) days after the date
on which Employee signs this Agreement (the “Effective Date”). For a period of seven (7) days following Employee’s
execution of this Agreement, Employee may revoke this Agreement, and this Agreement shall not become effective or enforceable until such
seven (7) day period has expired. Employee must communicate revocation of this Agreement in writing to the Employer no later than seven
(7) days following Employee’s execution of this Agreement. Employee’s signing of the Agreement triggers the commencement of
the seven (7) day revocation period.
2. In exchange for Employee’s execution of this Agreement and in full and complete settlement of any
claims as specifically provided in this Agreement, the Employer will provide Employee with the Transition Amounts in accordance with and
subject to the requirements of the Transition and Release Agreement.
3. Employee acknowledges and agrees that this Agreement is in compliance with the Age Discrimination in Employment
Act and the Older Workers Benefit Protection Act and that the releases set forth in this Agreement shall be applicable, without limitation,
to any claims brought under these Acts.
The release given by Employee in this
Agreement is given solely in exchange for the consideration set forth in Section 2 of this Agreement and such consideration is in addition
to anything of value that Employee was entitled to receive prior to entering into this Agreement.
Employee has been advised to consult
an attorney prior to entering into this Agreement, and this provision of the Agreement satisfies the requirement of the Older Workers
Benefit Protection Act that Employee be so advised in writing.
Exhibit B – Page 1
By entering into this Agreement, Employee
does not waive any rights or claims that may arise after the date this Agreement is executed.
4. This Agreement shall in no way be construed as an admission by Employer or Parent that it has acted wrongfully
with respect to Employee or any other person or that Employee has any rights whatsoever against Employer or Parent. Employer and Parent
specifically disclaim any liability to or wrongful acts against Employee or any other person on the part of themselves, their employees
or their agents.
5. As a material inducement to Employer and Parent to enter into this Agreement, Employee hereby irrevocably
releases Employer and Parent and each of the owners, stockholders, predecessors, successors, directors, officers, employees, representatives,
attorneys, affiliates (and agents, directors, officers, employees, representatives and attorneys of such affiliates) of Employer and Parent
and all persons acting by, through, under or in concert with them (collectively, the “Releasees”), from any and all
charges, claims, liabilities, agreements, damages, causes of action, suits, costs, losses, debts and expenses (including attorneys’
fees and costs actually incurred) of any nature whatsoever, known or unknown, including, but not limited to, rights arising out of alleged
violations of any contracts, express or implied, any covenant of good faith and fair dealing, express or implied, or any tort, or any
legal restrictions on Employer’s right to terminate employees, or any federal, state or other governmental statute, regulation,
or ordinance, including, without limitation: (1) Title VII of the Civil Rights Act of 1964, as amended by the Civil Rights Act of 1991
(race, color, religion, sex, and national origin discrimination); (2) the Employee Retirement Income Security Act (“ERISA”);
(3) 42 U.S.C. § 1981 (discrimination); (4) the Americans with Disabilities Act (disability discrimination); (5) the Equal Pay Act;
(6) the Age Discrimination in Employment Act; (7) the Older Workers Benefit Protection Act; (8) Executive Order 11246 (race, color,
religion, sex, and national origin discrimination); (9) Executive Order 11141 (age discrimination); (10) Section 503 of the Rehabilitation
Act of 1973 (disability discrimination); (11) negligence; (12) negligent hiring and/or negligent retention; (13) intentional or negligent
infliction of emotional distress or outrage; (14) defamation; (15) interference with employment; (16) wrongful discharge;
(17) invasion of privacy; or (18) violation of any other legal or contractual duty arising under the laws of the State of Maryland
or the laws of the United States (“Claim” or “Claims”), which Employee now has, or claims to have,
or which Employee at any time heretofore had, or claimed to have, or which Employee at any time hereinafter may have, or claim to have,
against each or any of the Releasees, in each case as to acts or omissions by each or any of the Releasees up to the time Employee signs
this Agreement.
6. The release in the preceding paragraph of this Agreement does not apply to any rights, payments or benefits
after the effective date of the termination of this Agreement for (a) base salary pursuant to Section 2(a) of the Employment Agreement
accrued up to the effective date of termination, (b) any rights to, amounts due under or vesting of any unvested and outstanding equity
awards or grants made by Parent or any of its “Affiliates” (as defined in the Employment Agreement) to Employee, as specified
according to the terms and conditions of such awards or grants or pursuant to any plans or documents otherwise governing such awards or
grants, as modified by Section 2(c) of the Transition and Release Agreement, (c) pay for accrued but unused vacation that Employer is
legally obligated to pay Employee, if any, and only if Employer is so obligated, (d) any rights as provided under the terms of any other
employee benefit and compensation agreements or plans applicable to Employee, (e) expenses required to be reimbursed pursuant to Section
2(d) of the Employment Agreement, (f) any rights Employee has under Section 2(h) of the Employment Agreement (including without limitation
any rights pursuant to that certain Directors and Officers Indemnification Agreement dated February 21, 2018 between Parent and Employee),
and (g) any rights the Employee may have (if any) to workers compensation benefits.
Exhibit B – Page 2
7. Employee promises that he will not make statements disparaging to any of the Releasees other than truthful
statements to any federal, state, or local governmental agencies regarding an investigation by or proceeding before such agency or a possible
violation of law or regulation. Employee agrees not to make any statements about any of the Releasees to the press (including without
limitation any newspaper, magazine, radio station or television station) or in any social or electronic media outlet without the prior
written consent of Employer. The obligations set forth in the two immediately preceding sentences will expire three years after the Effective
Date. Employee will also cooperate with Employer and its affiliates if Employer requests Employee’s testimony. To the extent practicable
and within the control of Employer, Employer will use reasonable efforts to schedule the timing of Employee’s participation in any
such witness activities in a reasonable manner to take into account Employee’s then current employment, and will pay the reasonable
documented out-of-pocket expenses that Employer pre-approves and that Employee incurs for travel required by Employer with respect to
those activities.
8. Except as set forth in this Section, Employee agrees not to disclose the existence or terms of this Agreement
to anyone. However, Employee may disclose it to a member of his immediate family or legal or financial advisors if necessary and on the
condition that the family member or advisor similarly does not disclose these terms to anyone. Employee understands that he will be responsible
for any disclosure by a family member or advisor as if he had disclosed it himself. This restriction does not prohibit Employee’s
disclosure of this Agreement or its terms to the extent necessary during a legal action to enforce this Agreement or to the extent Employee
is legally compelled to make a disclosure. However, Employee will notify Employer promptly upon becoming aware of that legal necessity
and provide it with reasonable details of that legal necessity. Notwithstanding any other provision hereof, Employee may disclose the
existence and terms of this Agreement directly to any federal, state, or local governmental agencies to the extent Employee is communicating
with such agency regarding an investigation by or proceeding before such agency or a possible violation of law or regulation, and in the
event of such communication, Employee is not required to notify or seek approval or authorization from Employer of such communication.
In addition, Employee may disclose the existence or terms of this Agreement to the following employees of the Company: Chief Executive
Officer (successor), President, Chief Financial Officer, Chief Accounting Officer, and Chief Legal Officer. The obligations set forth
in this paragraph will expire three years after the Effective Date.
Exhibit B – Page 3
9. Employee has not filed or caused to be filed any lawsuit, complaint or charge with respect to any Claim
he releases in this Agreement. Employee promises never to file or pursue a lawsuit, complaint or charge based on any Claim released by
this Agreement, except that Employee may participate in an investigation or proceeding conducted by an agency of the United States Government
or of any state. Notwithstanding the foregoing, Employee is not prohibited from filing a charge with the Equal Employment Opportunity
Commission but expressly waives his right to personal recovery as a result of such charge. Employee also has not assigned or transferred
any claim he is releasing, nor has he purported to do so. Notwithstanding any other provision hereof, Employee is not prohibited from
initiating or participating in an investigation or proceeding conducted by any federal, state, or local governmental agencies regarding
a possible violation of law or regulation or, other than in connection with a charge filed with the Equal Employment Opportunity Commission,
recovering a monetary award for initiating or participating in any such investigation or proceeding.
10. Employer, Parent and Employee agree that the terms of this Agreement shall be final and binding and that
this Agreement shall be interpreted, enforced and governed under the laws of the State of Maryland. The provisions of this Agreement can
be severed, and if any part of this Agreement is found to be unenforceable, the remainder of this Agreement will continue to be valid
and effective.
11. This Agreement sets forth the entire agreement among Employer, Parent and Employee and fully supersedes
any and all prior agreements or understandings, written and/or oral, between Employer and Employee pertaining to the subject matter of
this Agreement.
12. Employee is solely responsible for the payment of any fees incurred as the result of an attorney reviewing
this agreement on behalf of Employee. In any litigation concerning the validity or enforceability of this contract or in any litigation
to enforce the provisions of this contract, the prevailing party shall be entitled to recover reasonable attorneys’ fees and costs,
including court costs and expert witness fees and costs.
Employee’s signature below indicates Employee’s
understanding and agreement with all of the terms in this Agreement.
Employee should take this Agreement home and carefully
consider all of its provisions before signing it. Employee has been provided at least twenty-one (21) days to decide whether Employee
wants to accept and sign this Agreement. Also, if Employee signs this Agreement, Employee will then have an additional seven (7)
days in which to revoke Employee’s acceptance of this Agreement after Employee has signed it. This Agreement will not be
effective or enforceable, nor will any consideration be paid, until after the seven (7) day revocation period has expired. Again,
Employee is free and encouraged to discuss the contents and advisability of signing this Agreement with an attorney of Employee’s
choosing.
Employee
should read carefully. This agreement includes a release of all known and unknown claims through the effective date. Employee is strongly
advised to consult with an attorney before executing this document.
Exhibit B – Page 4
IN WITNESS WHEREOF, Parent,
Employer and Employee have executed this Agreement effective as of the date first written above.
OMEGA HEALTHCARE INVESTORS, INC.
By:
Gail D. Makode, Chief Legal Officer
OHI ASSET MANAGEMENT LLC
By:
Gail D. Makode, Chief Legal Officer
EMPLOYEE
By:
C. Taylor Pickett
Date Signed
Exhibit B – Page 5
EX-10.2 — EXHIBIT 10.2
EX-10.2
Filename: tm2615007d1_ex10-2.htm · Sequence: 3
Exhibit 10.2
Execution Version
CONSULTING AGREEMENT
This Consulting Agreement
(this “Agreement”) is entered as of May 19, 2026 to be effective as of October 2, 2026, by and between
Omega Healthcare Investors, Inc. (hereinafter “Omega” or the “Company”) and C. Taylor Pickett
(hereinafter “Consultant”).
RECITALS
WHEREAS,
until October 1, 2026, Consultant was an officer and director of Omega, as well as an officer and director of subsidiaries of Omega
(collectively, the “Omega Companies”);
WHEREAS,
Consultant has expertise in the area of Omega’s business and is willing to provide consulting services to Omega as set
forth herein; and
WHEREAS,
Omega is willing and desires to engage Consultant as an independent contractor, during the Term (as defined below), on the terms and conditions
set forth herein.
NOW,
THEREFORE, in consideration of the foregoing and of the mutual promises set forth herein, and intending to be legally bound,
the parties hereto agree as follows:
AGREEMENT
1.
Term; Termination; Rights on Termination.
(a)
This Agreement will commence on October 2, 2026, and unless modified by the mutual written agreement of the parties, shall continue until and through October 1, 2027 (as it may be extended, the “Term”), which shall be subject to extension by the Company (exercisable in the Company’s sole discretion) until and through April 1, 2028 to the extent the Company provides written notice to the Executive on or before October 1, 2027. This Agreement may be terminated at any time, with or without cause, by either party with ten (10) days written notice to the other party, and will also terminate if Consultant dies during the Term. The effectiveness of this Agreement is contingent upon Consultant signing on October 2, 2026, and returning on October 2, 2026 that certain Release Agreement and not revoking the Release Agreement within the revocation period provided therein.
(b)
If Omega terminates this Agreement during the Term, other than for Consultant’s willful failure or gross negligence in performing the consulting services described on Schedule A hereof (the “Services”) or due to a material breach of that certain Transition and Release Agreement dated May 19, 2026 (the “Transition Agreement”) or another agreement described therein, Consultant shall receive from Omega, the monthly Consulting Fee (defined below) then in effect for whatever time period is remaining under the Term. If Omega terminates this Agreement due to Consultant’s willful failure or gross negligence in performing the Services or due to a material breach of the Transition Agreement or another agreement described therein or Consultant terminates this Agreement during the Term or dies during the Term, the Company shall pay Consultant only so much of the monthly Consulting Fee as have accrued to the date of termination of this Agreement.
Page 1
2.
Compensation.
In consideration of the Services that may be performed by Consultant, Omega agrees to pay Consultant $20,000 per month during the Term as a retainer for Consultant’s services for Services of up to twenty (20) hours per month, subject to the maximum number of hours of services to be provided as described in Section 3(b) below, with monthly payments being made on or before the last business day of the month following provision of the Services during the Term of this Agreement (“Consulting Fee”). Should Consultant exceed 20 hours per month in provision of the Services, the Chief Executive Officer and Consultant shall mutually agree on any additional fee payable, if any. The Company may withhold from any amounts payable with respect to this Agreement such federal, state, local and other taxes as may be required to be withheld, if any, pursuant to any applicable law or regulation. As Consultant is not an employee of any of the Omega Companies, Consultant shall not be permitted to participate in any benefit plans of any of the Omega Companies, except for any right he has to participate in group health plans pursuant to COBRA as a result of a termination of employment.
3.
Terms and Scope of Services.
(a)
This Agreement shall control and govern all work performed by Consultant. No subsequent variance from, amendment to or modification of this Agreement shall be binding upon the Omega Companies unless it is in writing, expressly provides that it is intended as a variance, amendment or modification and is executed by a fully authorized representative of the Omega Companies.
(b)
The scope of services to be provided hereunder is set forth in Schedule A hereto and as further modified and amended under subsequent written agreements between the parties.
(c)
All travel and out-of-pocket expenses incurred by Consultant for the benefit of the Omega Companies and in the performance of this agreement that are approved by the Company, shall be reimbursed by the Company within ten (10) business days following presentation of valid expense receipts.
(d)
All payments to Consultant hereunder will be reported on Form 1099, and Consultant agrees to accept exclusive liability for the payment of all taxes, contributions for unemployment insurance, old age and survivor’s insurance or annuities, which are based on the fees and expense reimbursements paid to Consultant; and Consultant agrees to reimburse Omega for any of the aforesaid taxes or contributions which by law Omega may be required to pay because of Consultant’s failure to pay the same.
(e)
Consultant acknowledges that the Company makes no warranties as to any tax consequences regarding payment of the Consulting Fee, and Consultant shall solely be responsible for payment of his own taxes.
Page 2
(f)
Consultant, as an independent contractor, shall personally perform the services rendered under this Agreement and may not subcontract or delegate his duties to any other party. It is specifically understood and agreed that the manner and means of performing the services required under this Agreement shall be at the sole discretion of the Consultant through use of his independent judgment. Subject to Section 3(b), Consultant shall devote sufficient business time and efforts to the performance of services for the Company to complete the services within the time frames for completion established by the Company. Consultant shall use Consultant’s best efforts in such endeavors. Consultant shall also perform Consultant’s services with a level of care, skill, and diligence that a prudent professional acting in a like capacity and familiar with such matters would use.
(g)
Consultant shall have no authority to bind the
Omega Companies or any of its officers or employees to any agreement or to make managerial or Consultant decisions that are binding on
the Omega Companies. Consultant shall not be subject to the supervision, direction or control of the Omega Companies as to the particular
means or methods of performing his services. However, the Omega Companies shall retain the right to review and inspect at any time any
part of the work performed by Consultant to assure compliance with appropriate standards and specifications.
(h)
Upon request or when Consultant’s relationship with the Company terminates, Consultant will immediately deliver to the Company all copies of any and all materials and writings received from, created for, or belonging to the Company including, but not limited to, those which relate to or contain proprietary or confidential information, consistent with the requirements of the Intellectual Property Agreement.
4.
Indemnification. The Company will indemnify Consultant for expenses actually and reasonably incurred that directly result from any claims made against Consultant arising out of any actions by Consultant that are within the scope of services, and consistent with the standards of performance, required under this Agreement, except to the extent that the Consultant’s actions were dishonest, were in bad faith, were opposed to the interests of the Company, involved an improper personal benefit to Consultant, involved criminal conduct by Consultant or were grossly negligent; provided, however, as a condition of indemnification, Consultant must promptly notify the Company of each claim that may give rise to indemnification hereunder and all relevant facts of which Consultant is aware and, unless the Company has a conflict of interest, the Consultant must allow the Company to assume the defense of the claim.
5.
Entire Agreement.
This Agreement contains the entire understanding and agreement between the parties hereto with respect to its subject matter and supersedes
any prior or contemporaneous written or oral agreements, representations or warranties between them respecting the subject matter hereof,
other than the Transition and Release Agreement entered into between Consultant and Omega.
6.
Amendment. This Agreement may be amended only by a writing signed by Consultant and by a duly authorized officer of Omega.
Page 3
7.
Remedy for Breach. Should either Consultant or Omega resort to legal proceedings to enforce this Agreement, the prevailing party in such legal proceeding shall be awarded, in addition to such other relief as may be granted, attorneys’ fees and costs incurred in connection with such proceeding.
8.
Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The parties agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy arising under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The parties consent to the jurisdiction of such courts.
9.
Duplicate.
This Agreement may be executed in duplicate originals and is not effective unless signed by both parties.
IN WITNESS WHEREOF,
Omega and Consultant have executed this Agreement effective as of the date first written above.
Consultant
Omega Healthcare Investors, Inc.
By:
/s/ C. Taylor Pickett
By
/s/ Gail D. Makode
C. Taylor Pickett
Gail D. Makode, Chief Legal Officer
Page 4
SCHEDULE A
SCOPE OF SERVICES
Consultant shall render such transitional support
services and perform such individual projects as may be requested by the Chief Executive Officer or the Board of Directors of Omega from
time to time during the Term (the “Services”).
Schedule A – Page 1
EX-10.3 — EXHIBIT 10.3
EX-10.3
Filename: tm2615007d1_ex10-3.htm · Sequence: 4
Exhibit 10.3
Execution Version
TRANSITION AGREEMENT AND RELEASE
THIS TRANSITION AGREEMENT
AND RELEASE (the “Agreement”) is made effective as of May 19, 2026 (the “Effective Date”),
except as otherwise provided herein, among Omega Healthcare Investors, Inc. (“Parent”), Omega Asset Management
LLC (the “Company”) and Robert O. Stephenson (“Executive”). The Parent, the Company and the Executive,
when collectively referred to, are hereinafter identified as the “Parties”.
INTRODUCTION
Effective August 1, 2026
(the “Transition Effective Date”), Executive will terminate employment from, and cease to hold any positions with,
the Company and its “Affiliates,” which shall mean, for purposes of this Agreement, any person, firm, corporation,
partnership, association or entity that, directly or indirectly or through one or more intermediaries, controls, is controlled by or is
under common control with the Company, as determined by the Company; and the term of the Employment Agreement effective January 1,
2026 as amended, among Parent, the Company and Executive (the “Employment Agreement”) is hereby terminated as of August 1,
2026. In addition, effective as of August 2, 2026, Parent and Executive shall enter into a Consulting Agreement (the “Consulting
Agreement”), substantially in the form attached as Exhibit A hereto, pursuant to which Executive shall perform business
consulting and business advisory services to Parent and its Affiliates from and after August 2, 2026 through August 1, 2027
(the “Initial Consulting Term”), subject to extension at Parent’s option through February 1, 2028 (the “Extended
Consulting Term”, with the Initial Consulting Term and, if extended, the Extended Consulting Term, being referred to as the
“Consulting Term”). As a result of the level of services expected under the Consulting Agreement, Executive is expected
to incur a “Separation from Service” within the meaning of Section 409A of the Internal Revenue Code on August 1,
2026. Pursuant to the Employment Agreement, Executive’s termination of employment on August 1, 2026, constitutes a termination
of employment by the Company without “Cause,” as defined in the Employment Agreement, and as a result, Executive will
be entitled to certain payments. Further, the Company recognizes that due in part to Executive’s long tenure with the Company and
its Affiliates, Executive has unique knowledge, experience and skills, and the Company has a unique need to engage Executive for an interim
period to assist in a smooth transition of his duties and knowledge to other officers. Accordingly, the Parties desire to enter into this
Agreement pursuant to which Executive agrees to continue to be employed until the Transition Effective Date, will be entitled to certain
other incentive compensation and agrees to provide transitional consulting services to the Company during the Consulting Term, in each
case upon the terms set forth below.
NOW, THEREFORE, the Parties
agree as follows:
1. Terms
and Conditions of Engagement.
(a) Transitional
Employment and Consulting Agreement. The Company and Executive agree that Executive shall remain employed by the Company until the
Transition Effective Date, and Parent and Executive shall enter into the Consulting Agreement effective August 2, 2026, pursuant
to which Executive shall perform such business consulting and business advisory services to Parent and its Affiliates as Parent may require
from time to time during the Consulting Term.
2. Compensation.
The Parties hereby agree that,
in consideration for Executive’s promises contained herein, the Executive shall remain employed in his current role and be paid
his base salary at his current rate through and until the Transition Effective Date, as well as continue participation in any Company
benefit plans through and until the Transition Effective Date. Further, in consideration for Executive’s promises contained herein,
and provided that Executive executes this Agreement and returns it to the Company by the Effective Date, executes and returns to the Company
the Release Agreement described in Section 2(e) hereof on the first business day after the Transition Effective Date, and does
not challenge any portion of this Agreement, including the Release Agreement, or revoke the Release Agreement within the revocation period
provided therein, and provided that Executive complies with this Agreement, the Employment Agreement the Parent’s Code of Business
Conduct and Ethics (which the Parties agree, shall for all purposes of this Agreement continue to apply to the Executive in his capacity
as a consultant pursuant to the Consulting Agreement to the same extent as if he continued to be an officer of the Parent), the Consulting
Agreement and the Intellectual Property Agreement (as defined below), Executive shall be entitled to receive the following amounts (collectively
referred to herein as the “Transition Amounts”), in addition to any consulting fees payable pursuant to the Consulting
Agreement:
(a) Benefits.
Following the Transition Effective Date, should Executive elect to receive benefits through COBRA,
Executive shall be entitled to, in accordance with Section 3(c)(i)(B) of
the Employment Agreement, payment of 100% of the applicable monthly COBRA premium under the Company’s group health plan for the
coverage elected by Executive, his spouse and his eligible dependents, continued for the lesser of eighteen (18) month or until such COBRA
coverage for Executive (or his spouse or dependents) terminates, which the Company shall pay directly to its group health plan insurer
on Executive’s behalf, provided however, that if such payment would violate applicable law or result in liability or penalties under
applicable law, the Company shall instead pay Executive a taxable amount equal to the amount of each such monthly premium, with one-half
of each monthly premium being added to each of the two monthly installment payments in clause (b) below until all such required taxable
amounts have been paid. In addition, the Company shall cooperate with Employee to cause Employee’s supplemental life insurance policy
to remain in effect following Employee’s termination of employment and to cause the transfer of any and all benefits under such
policy to Employee as of such time, in each case subject to the consent and requirements of the respective insurance carrier and the terms
of such insurance policy, and provided that Employee assumes the full responsibility for any premiums owing under such policy following
the Transition Effective Date and any tax liability associated the transfer of such policy benefits to Employee.
(b) Transition
Payment and 2026 Short-Term Incentive.
(i) The
Company shall pay to Executive the gross sum of $2,481,333, equal to two times the sum of (A) Executive’s annual base
salary plus (B) an amount equal to Executive’s “Average Annual Bonus” as defined in the Employment Agreement (the
“Transition Payment”), in accordance with Section 3(c)(i)(A) of the Employment Agreement. Executive acknowledges
and agrees that payment of the Transition Payment shall be made in substantially equal installments not less frequently than twice per
month over the twenty-four (24) month period commencing as of the day following his Separation from Service, provided that, the first
payment shall be made sixty (60) days following the date of Separation from Service (or the first business day following such 60 day period)
and shall include all payments accrued following the date of Separation from Service to the date of the first payment.
2
(ii) 2026
Short-Term Incentive. The Company shall pay Executive the short-term incentive that is earned based on performance for 2026, determined
without proration for the fact that the Executive’s Separation from Service will occur before the end of 2026 and without regard
to the fact that the Executive will not be an employee of the Company on the date that such short-term incentive is paid. This amount
will be payable on the same date that the short-term incentives for 2026 performance are payable to the executive officers of the Company.
(c) Equity
Awards. In accordance with Section 3(b) of the Employment Agreement, Executive shall be entitled to any rights to and amounts
due under any unvested and outstanding equity awards made by Parent or any of its Affiliates to Executive, as specified according to the
terms and conditions of such awards or grants or pursuant to any plans or documents otherwise governing such awards or grants, provided
that, if Executive executes and returns this Agreement, complies with the Consulting Agreement and does not terminate the Consulting Agreement
before the end of the Consulting Term and the Company does not terminate the Consulting Agreement before the end of the Consulting Term
due to breach by Executive, such awards shall vest to the same extent as if Executive provided services through the date required for
100% vesting. The Parties agree that the proviso in the prior sentence replaces and supersedes and extinguishes any vesting terms that
require proration of units otherwise provided for in the applicable terms and conditions of such awards or grants or pursuant to any plans,
documents or policies otherwise governing such awards or grants. For the avoidance of doubt, the amounts of all such outstanding equity
awards due to Executive hereunder are limited to the amounts specified below, but otherwise remain subject to all the terms and conditions
of such equity awards:
(i) Time-Based Awards. Subject to Sections 2(e), (f) and (g), 3, 4 and 5, Executive shall vest
in a total of 72,780 time-based profits interest units under the Time-Based Profits Interest Units Award Agreements issued by Parent effective
January 1, 2024, January 1, 2025 and January 1, 2026 on the same dates as if he continued to be employed through December 31,
2028. The 72,780 units are comprised of 28,340 units under the January 1, 2024 award agreement, 23,641 units under the January 1,
2025 award agreement and 20,799 units under the January 1, 2026 award agreement.
(ii) Performance-Based Awards. Subject to Sections 2(e), (f) and (g), 3, 4, and 5, Executive shall
vest in the same number of performance profits interest units under the agreements below on the same dates as if he continued to be employed
through December 31, 2029. The number of units, in the case of the January 1, 2023 grants, is the actual number of units
earned as set forth below (which includes the number already quarterly vested in 2026), and in the case of the January 1, 2024, January 1,
2025, and January 1, 2026 grants, the number of units will be based on the applicable level of performance achieved (below threshold
(in which case nothing will vest), threshold, target or high) and are based on an assumption that a “Change in Control” (as
defined in such agreements) does not occur during the applicable “Performance Period” (as defined in such agreements). If
a Change in Control does occur during the applicable Performance Period, the number of vested units will be determined under the applicable
agreement, as modified by this subsection.
3
Agreement
Performance-Based Units
Actual Number Earned
1/1/2023
for 12/31/2025 Performance Period end
-TSR-Based Performance Profit Interests Units Award Agreement
115,078
-Relative TSR-Based Performance Profit Interests Units Award Agreement
43,516
Threshold
Target
High
1/1/2024
for 12/31/2026 Performance Period end
-TSR-Based Profits Interests Units Award Agreement
7,043
44,274
127,922
- Relative TSR-Based Performance Profit Interests Units Award Agreement
6,520
42,746
131,450
1/1/2025
for 12/31/2027 Performance Period end
-TSR-Based Performance Profit Interests Units Award Agreement
6,058
38,263
111,524
-Relative TSR-Based Performance Profit Interests Units Award Agreement
4,945
32,074
97,173
1/1/2026
for 12/31/2028 Performance Period end
-TSR-Based Performance Profit Interests Units Award Agreement
5,540
35,402
105,120
-Relative TSR-Based Performance Profit Interests Units Award Agreement
4,151
27,153
83,742
(d) Expenses.
Executive shall be entitled to be reimbursed in accordance with Company policy for reasonable and necessary expenses incurred by Executive
in connection with the performance of Executive’s duties of employment hereunder through the Transition Effective Date in accordance
with the Employment Agreement.
(e) Release
Contingency. The payments to Executive required by Sections 2(a) through 2(c) are contingent upon Executive executing the
Release Agreement attached hereto as Exhibit B (the “Release Agreement”) on, and delivering it to the Company,
on the first business day after the Transition Effective Date, and not revoking the Release Agreement in accordance with its procedures
within the revocation period provided in the Release Agreement. If Executive fails to timely execute and deliver the Release Agreement
or if Executive revokes the Release Agreement within the revocation period provided in the Release Agreement, this Agreement shall thereupon
automatically terminate, without the requirement of any further action by any party, provided that the provisions of Sections 4 and 5
hereof shall continue to apply to Executive.
4
(f) Section 409(a).
All payments provided for in this Agreement are intended to be exempt from Section 409A of the Internal Revenue Code (“Code
Section 409A”) to the maximum extent possible, and any payments that are subject to Code Section 409A are intended
to be compliant therewith, and this Agreement shall be construed consistent with such intent. For purposes of Code Section 409A,
each the entitlement to a series of installment payments hereunder will be treated as the right to a series of separate payments to the
extent not inconsistent with any other agreement to which Executive is subject. Notwithstanding any other provision hereof if the Executive
is a “specified employee” within the meaning of Code Section 409A at the date of his separation from service, then if,
and solely to the extent, required to avoid a tax under Code Section 409A, payments which would otherwise have been made during the
first six (6) months after separation from service shall be withheld and paid to the Executive during the seventh month following
the date of his termination of employment. While the Company intends that no payment under this Agreement shall be subject to tax under
Code Section 409A, the Company provides no guarantee of tax consequences to Executive and Executive shall be responsible for Executive’s
own taxes. Notwithstanding the foregoing, if the total payments to be paid to Executive hereunder, along with any other payments to Executive,
would result in Executive being subject to the excise tax imposed by Code Section 4999, the Company shall reduce the aggregate payments
to the largest amount which can be paid to Executive without triggering the excise tax, but only if and to the extent that such reduction
would result in Executive retaining larger aggregate after-tax payments. The determination of the excise tax and the aggregate after-tax
payments to be received by Executive will be made by the Company after consultation with its advisors and in material compliance with
applicable law. For this purpose, the Parties agree that the payments provided for in Section 3(c)(i) of the Employment Agreement
are intended to be reasonable compensation for refraining from performing services after termination of employment (i.e., Executive’s
obligations pursuant to Sections 4, 5 and 6 of the Employment Agreement) to the maximum extent possible, and if necessary or desirable,
the Company will retain a valuator or consultant to determine the amount constituting reasonable compensation. If payments are to be reduced,
to the extent permissible under Code Section 4999, payments will be reduced in a manner that maximizes the after-tax economic benefit
to Executive and to the extent consistent with that objective, in the following order of precedence: (A) first, payments will be
reduced in order of those with the highest ratio of value for purposes of the calculation of the parachute payment to projected actual
taxable compensation to those with the lowest such ratio, (B) second, cash payments will be reduced before non-cash payments, and
(C) third, payments to be made latest in time will be reduced first. Any reduction will be made in a manner that is intended to avoid
a tax being incurred under Code Section 409A.
(g) Incentive
Recovery Policy. Pursuant to Section 8 of the Employment Agreement, Executive has agreed to be bound by the Company’s Incentive
Compensation Recovery Policy, as amended, and that this provision shall survive termination of the Employment Agreement and this Agreement.
(h) Death
or Disability. If Executive dies or becomes subject to a “Disability” (as defined in the Employment Agreement) after the
Effective Date while employed by the Company or while he is a consultant during the Consulting Term and was otherwise in full compliance
with all of the provisions of this Agreement through his date of death or Disability, the payments and benefits provided for herein shall
accrue and be paid to Executive, or the legal representative of Executive’s estate in the case of death, other than any unearned
fees pursuant to the terms of the Consulting Agreement, and in addition, the unpaid installments of the Transition Payment described in
Section 2(b)(i) shall be paid within sixty (60) days following the date of death or the Disability (provided the Disability
is of a type that meets the requirements of Section 409A of the Internal Revenue Code), and the vesting of the profits interest units
described in Section 2(c) shall be accelerated to the date of death or Disability, or in the case of the performance-based profits
interest units, the last day of the applicable Performance Period(s) if later than the date of death or Disability.
5
3. Termination.
(a) Termination.
This Agreement may be terminated only: (i) by mutual agreement of the Parties; (ii) as provided in Section 2, as a result
of the failure of Executive to timely execute and deliver the Release Agreement or as a result of Executive revoking the Release Agreement;
or (iii) by the Company, as a result of Executive’s material breach of this Agreement, the Employment Agreement, the Parent’s
Code of Business Conduct and Ethics, the Consulting Agreement or the Intellectual Property Agreement (only if the Company has first given
Executive written notice of the breach and a reasonable opportunity to cure the same) or as a result of the Company terminating Executive’s
employment for “Cause” (as defined in the Employment Agreement) pursuant to the provisions of the Employment Agreement. Notice
of termination shall be given prior to termination in writing and shall specify the effective date of termination. Except for earned and
accrued salary and benefits and expenses under Sections 2 and 2(d), Executive shall not be entitled to any payments or vesting provided
for in Section 2 if this Agreement is terminated under clauses (ii) or (iii) above.
(b) Survival.
The covenants of Executive in Sections 4 and 5 hereof and shall survive the termination of this Agreement and shall not be extinguished
thereby.
4. Restrictive
Covenants.
Executive previously agreed
pursuant to Sections 4, 5, 6 and 8 of the Employment Agreement to be subject to certain nondisclosure, cooperation, noncompetition, nonsolicitation
and nondisparagement obligations, as well as the Company’s Incentive Compensation Recovery Policy, as amended, and the Intellectual
Property Agreement between Company and the Executive dated as of August 28, 2024 (the “Intellectual Property Agreement”),
each of which survived his termination of employment. Executive confirms that he agrees to comply with his obligations pursuant to Sections
4, 5, 6 and 8 of the Employment Agreement and that Executive’s compliance with the same shall be a condition of his receiving the
amounts and benefits provided for under Sections 2(a) through 2(c) hereof.
5. Remedies
and Enforceability.
Executive agrees that the
covenants, agreements, and representations contained in Section 4 hereof are of the essence of this Agreement; that each of such
covenants are reasonable and necessary to protect and preserve the interests and properties of the Company and its Affiliates; that irreparable
loss and damage will be suffered by the Company and its Affiliates should Executive breach any of such covenants and agreements; that
each of such covenants and agreements is separate, distinct and severable not only from the other of such covenants and agreements but
also from the other and remaining provisions of this Agreement; that the unenforceability of any such covenant or agreement shall not
affect the validity or enforceability of any other such covenant or agreements or any other provision or provisions of this Agreement;
and that if Executive materially breaches a covenant in Section 4 hereof or materially breaches this Agreement, the Employment Agreement,
the Intellectual Property Agreement or the Consulting Agreement, (a) Executive shall forfeit all compensation under Sections 2(a) through
2(c), including compensation that has already been paid and compensation that has already vested, and Executive shall immediately upon
the Company’s demand repay all such compensation as has already been paid, and (b) the Company and Parent shall be entitled
to seek both temporary and permanent injunctions to prevent a breach or contemplated breach by Executive of any of such covenants or agreements,
in addition to other remedies available to them.
6
6. Notice.
All notices, requests, demands
and other communications required hereunder shall be in writing and shall be deemed to have been duly given if delivered or if mailed,
by United States certified or registered mail, prepaid to the party to which the same is directed at the following addresses (or at such
other addresses as shall be given in writing by the Parties to one another):
If to the Company:
Omega Healthcare Investors, Inc.
303 International Circle, Suite 200
Hunt Valley, MD 21030
Attn: Chief Legal Officer, General Counsel
If to Executive:
to the last address the Company
has on file for Executive
Notices delivered in person shall be effective on the date of delivery.
Notices delivered by mail as aforesaid shall be effective upon the fourth calendar day subsequent to the postmark date thereof.
7. Miscellaneous.
(a) Assignment.
The rights and obligations of the Company and Parent under this Agreement shall inure to the benefit of the Company’s and Parent’s
successors and assigns. This Agreement may be assigned by the Company or Parent to any legal successor to the Company’s or Parent’s
business or to an entity that purchases all or substantially all of the assets of the Company or Parent, but not otherwise without the
prior written consent of Executive. Executive may not assign this Agreement.
(b) Tax
Withholding. All payments hereunder shall be reduced by applicable tax withholding and all other lawful deductions.
(c) Waiver.
The waiver of any breach of this Agreement by any party shall not be effective unless in writing, and no such waiver shall constitute
the waiver of the same or another breach on a subsequent occasion.
(d) Governing
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The Parties
agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy arising
under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The Parties consent
to the jurisdiction of such courts.
7
(e) Entire
Agreement. This Agreement embodies the entire agreement of the Parties hereto relating to the subject matter hereof and supersedes
all oral agreements, and to the extent inconsistent with the terms hereof, all other written agreements. The Parties agree that the term
of the Employment Agreement is terminated effective on the Transition Effective Date and that the Employment Agreement is hereby terminated
on the Transition Effective Date, except as to the terms which survive termination, including without limitation Sections 4 and 5 of the
Employment Agreement. As of the Transition Effective Date, Executive resigns from all positions that he holds with Parent, the Company
and the Affiliates.
(f) Amendment.
This Agreement may not be modified, amended, supplemented or terminated except by a written instrument executed by the Parties hereto.
(g) Severability.
Each of the covenants and agreements hereinabove contained shall be deemed separate, severable and independent covenants, and in the event
that any covenant shall be declared invalid by any court of competent jurisdiction, such invalidity shall not in any manner affect or
impair the validity or enforceability of any other part or provision of such covenant or of any other covenant contained herein.
(h) Captions
and Section Headings. Captions and section headings used herein are for convenience only and are not a part of this Agreement
and shall not be used in construing it.
8
IN
WITNESS WHEREOF, Parent, the Company and Executive have each executed and delivered this Agreement as of the date first shown
above.
OMEGA HEALTHCARE INVESTORS, INC.
By:
/s/ C. Taylor Pickett
C. Taylor Pickett, Chief Executive Officer
OHI ASSET MANAGEMENT LLC
By:
/s/ C. Taylor Pickett
C. Taylor Pickett, Chief Executive Officer
EXECUTIVE
By:
/s/ Robert O. Stephenson
Robert O. Stephenson
9
EXHIBIT A
CONSULTING AGREEMENT
Exhibit A
CONSULTING AGREEMENT
This Consulting Agreement
(this “Agreement”) is entered as of May 19, 2026 to be effective as of August 2, 2026, by and between Omega
Healthcare Investors, Inc. (hereinafter “Omega” or the “Company”) and Robert O. Stephenson
(hereinafter “Consultant”).
RECITALS
WHEREAS,
until August 1, 2026, Consultant was an officer of Omega, as well as an officer and director of subsidiaries of Omega (collectively,
the “Omega Companies”);
WHEREAS,
Consultant has expertise in the area of Omega’s business and is willing to provide consulting services to Omega as set
forth herein; and
WHEREAS,
Omega is willing and desires to engage Consultant as an independent contractor, during the Term (as defined below), on the terms and conditions
set forth herein.
NOW,
THEREFORE, in consideration of the foregoing and of the mutual promises set forth herein, and intending to be legally bound,
the parties hereto agree as follows:
AGREEMENT
1.
Term; Termination; Rights on Termination.
(a)
This Agreement will commence on August 2,
2026, and unless modified by the mutual written agreement of the parties, shall continue until and through August 1, 2027 (as it
may be extended, the “Term”), which shall be subject to extension by the Company (exercisable in the Company’s
sole discretion) until and through February 1, 2028 to the extent the Company provides written notice to the Executive on or before
August 1, 2027. This Agreement may be terminated at any time, with or without cause, by either party with ten (10) days written
notice to the other party, and will also terminate if Consultant dies during the Term. The effectiveness of this Agreement is contingent
upon Consultant signing on August 2, 2026, and returning on August 2, 2026 that certain Release Agreement and not revoking the
Release Agreement within the revocation period provided therein.
Exhibit A - Page 1
(b)
If Omega terminates this Agreement during the Term, other than for Consultant’s willful failure or gross negligence in performing the consulting services described on Schedule A hereof (the “Services”) or due to a material breach of that certain Transition and Release Agreement dated May 19, 2026 (the “Transition Agreement”) or another agreement described therein, Consultant shall receive from Omega, the monthly Consulting Fee (defined below) then in effect for whatever time period is remaining under the Term. If Omega terminates this Agreement due to Consultant’s willful failure or gross negligence in performing the Services or due to a material breach of the Transition Agreement or another agreement described therein or Consultant terminates this Agreement during the Term or dies during the Term, the Company shall pay Consultant only so much of the monthly Consulting Fee as have accrued to the date of termination of this Agreement.
2.
Compensation.
In consideration of the Services that may be performed by Consultant, Omega agrees to pay Consultant $12,000 per month during the Term as a retainer for Consultant’s services for Services of up to twenty (20) hours per month, subject to the maximum number of hours of services to be provided as described in Section 3(b) below, with monthly payments being made on or before the last business day of the month following provision of the Services during the Term of this Agreement (“Consulting Fee”). Should Consultant exceed 20 hours per month in provision of the Services, the Chief Executive Officer and Consultant shall mutually agree on any additional fee payable, if any. The Company may withhold from any amounts payable with respect to this Agreement such federal, state, local and other taxes as may be required to be withheld, if any, pursuant to any applicable law or regulation. As Consultant is not an employee of any of the Omega Companies, Consultant shall not be permitted to participate in any benefit plans of any of the Omega Companies, except for any right he has to participate in group health plans pursuant to COBRA as a result of a termination of employment.
3.
Terms and Scope of Services.
(a)
This Agreement shall control and govern all work performed by Consultant. No subsequent variance from, amendment to or modification of this Agreement shall be binding upon the Omega Companies unless it is in writing, expressly provides that it is intended as a variance, amendment or modification and is executed by a fully authorized representative of the Omega Companies.
(b)
The scope of services to be provided hereunder is set forth in Schedule A hereto and as further modified and amended under subsequent written agreements between the parties. It is understood that the number of hours of services to be provided hereunder per month are expected over the Term not to exceed twenty percent (20%) of the time worked by Consultant per month for the Omega Companies averaged over the thirty-six month period before the first day of the Term.
Exhibit A - Page 2
(c)
All travel and out-of-pocket expenses incurred by Consultant for the benefit of the Omega Companies and in the performance of this agreement that are approved by the Company, shall be reimbursed by the Company within ten (10) business days following presentation of valid expense receipts.
(d)
All payments to Consultant hereunder will be reported on Form 1099, and Consultant agrees to accept exclusive liability for the payment of all taxes, contributions for unemployment insurance, old age and survivor’s insurance or annuities, which are based on the fees and expense reimbursements paid to Consultant; and Consultant agrees to reimburse Omega for any of the aforesaid taxes or contributions which by law Omega may be required to pay because of Consultant’s failure to pay the same.
(e)
The level of Consultant’s services under this Agreement is intended to result in a “separation from service” (as defined under Section 409A of the Internal Revenue Code) occurring on August 1, 2026. Consultant acknowledges that the Company makes no warranties as to any tax consequences regarding payment of the Consulting Fee, and Consultant shall solely be responsible for payment of his own taxes.
(f)
Consultant, as an independent contractor, shall personally perform the services rendered under this Agreement and may not subcontract or delegate his duties to any other party. It is specifically understood and agreed that the manner and means of performing the services required under this Agreement shall be at the sole discretion of the Consultant through use of his independent judgment. Subject to Section 3(b), Consultant shall devote sufficient business time and efforts to the performance of services for the Company to complete the services within the time frames for completion established by the Company. Consultant shall use Consultant’s best efforts in such endeavors. Consultant shall also perform Consultant’s services with a level of care, skill, and diligence that a prudent professional acting in a like capacity and familiar with such matters would use.
(g)
Consultant shall have no authority to bind the
Omega Companies or any of its officers or employees to any agreement or to make managerial or Consultant decisions that are binding on
the Omega Companies. Consultant shall not be subject to the supervision, direction or control of the Omega Companies as to the particular
means or methods of performing his services. However, the Omega Companies shall retain the right to review and inspect at any time any
part of the work performed by Consultant to assure compliance with appropriate standards and specifications.
(h)
Upon request or when Consultant’s relationship with the Company terminates, Consultant will immediately deliver to the Company all copies of any and all materials and writings received from, created for, or belonging to the Company including, but not limited to, those which relate to or contain proprietary or confidential information, consistent with the requirements of the Intellectual Property Agreement.
Exhibit A - Page 3
4.
Indemnification. The Company will indemnify Consultant for expenses actually and reasonably incurred that directly result from any claims made against Consultant arising out of any actions by Consultant that are within the scope of services, and consistent with the standards of performance, required under this Agreement, except to the extent that the Consultant’s actions were dishonest, were in bad faith, were opposed to the interests of the Company, involved an improper personal benefit to Consultant, involved criminal conduct by Consultant or were grossly negligent; provided, however, as a condition of indemnification, Consultant must promptly notify the Company of each claim that may give rise to indemnification hereunder and all relevant facts of which Consultant is aware and, unless the Company has a conflict of interest, the Consultant must allow the Company to assume the defense of the claim.
5.
Entire Agreement. This Agreement contains the entire understanding and agreement between the parties hereto with respect to its subject matter and supersedes any prior or contemporaneous written or oral agreements, representations or warranties between them respecting the subject matter hereof, other than the Transition and Release Agreement entered into between Consultant and Omega.
6.
Amendment. This Agreement may be amended only by a writing signed by Consultant and by a duly authorized officer of Omega.
7.
Remedy for Breach. Should either Consultant or Omega resort to legal proceedings to enforce this Agreement, the prevailing party in such legal proceeding shall be awarded, in addition to such other relief as may be granted, attorneys’ fees and costs incurred in connection with such proceeding.
8.
Governing
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The
parties agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy
arising under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The parties
consent to the jurisdiction of such courts.
9.
Duplicate.
This Agreement may be executed in duplicate originals and is not effective unless signed by both parties.
IN WITNESS WHEREOF,
Omega and Consultant have executed this Agreement effective as of the date first written above.
Consultant
Omega Healthcare Investors, Inc.
By:
By
Robert O. Stephenson
C. Taylor Pickett, Chief Executive Officer
Exhibit A - Page 4
SCHEDULE A
SCOPE OF SERVICES
Consultant shall render such transitional support
services and perform such individual projects as may be requested by the Chief Executive Officer of Omega from time to time during the
Term (the “Services”). All services rendered and performance thereof shall be at the direction of the Chief Executive
Officer of Omega.
Exhibit A - Schedule A
EXHIBIT B
RELEASE AGREEMENT
Exhibit B
RELEASE AGREEMENT
This Agreement (this “Agreement”)
is made August 2, 2026, among Omega Healthcare Investors, Inc. (“Parent”), OHI Asset Management LLC (“Employer”),
and Robert O. Stephenson (“Employee”).
Introduction
On August 1, 2026, Employee
ceased to be employed as an employee of the Company and an executive officer of Parent and the Company as provided in that certain Transition
and Release Agreement dated May 19, 2026 (the “Transition and Release Agreement”). Effective August 2, 2026,
Employer, Parent and Employee entered into a Consulting Agreement (the “Consulting Agreement”).
The Transition and Release
Agreement requires that as a condition to Employee’s right to receive payments and vesting under Sections 2(a) through 2(c) thereunder
(the “Transition Amounts”) and as a condition to the effectiveness of the Consulting Agreement, Employee must execute
this Agreement.
NOW,
THEREFORE, the parties agree as follows:
1. Employee has been offered at least twenty-one (21) days from receipt of this Agreement within which to
consider this Agreement, and to become effective this Agreement must be signed by Employee on (and not before or after) August 2,
2026, and returned to Employer on that same date. The effective date of this Agreement shall be the date eight (8) days after
the date on which Employee signs this Agreement (the “Effective Date”). For a period of seven (7) days following
Employee’s execution of this Agreement, Employee may revoke this Agreement, and this Agreement shall not become effective or enforceable
until such seven (7) day period has expired. Employee must communicate revocation of this Agreement in writing to the Employer no
later than seven (7) days following Employee’s execution of this Agreement. Employee’s signing of the Agreement triggers
the commencement of the seven (7) day revocation period.
2. In exchange for Employee’s execution of this Agreement and in full and complete settlement of any
claims as specifically provided in this Agreement, the Employer will provide Employee with the Transition Amounts in accordance with and
subject to the requirements of the Transition and Release Agreement.
3. Employee acknowledges and agrees that this Agreement is in compliance with the Age Discrimination in Employment
Act and the Older Workers Benefit Protection Act and that the releases set forth in this Agreement shall be applicable, without limitation,
to any claims brought under these Acts.
The release given by Employee in this
Agreement is given solely in exchange for the consideration set forth in Section 2 of this Agreement and such consideration is in
addition to anything of value that Employee was entitled to receive prior to entering into this Agreement.
Employee has been advised to consult
an attorney prior to entering into this Agreement, and this provision of the Agreement satisfies the requirement of the Older Workers
Benefit Protection Act that Employee be so advised in writing.
Exhibit B - Page 1
By entering into this Agreement, Employee
does not waive any rights or claims that may arise after the date this Agreement is executed.
4. This Agreement shall in no way be construed as an admission by Employer or Parent that it has acted wrongfully
with respect to Employee or any other person or that Employee has any rights whatsoever against Employer or Parent. Employer and Parent
specifically disclaim any liability to or wrongful acts against Employee or any other person on the part of themselves, their employees
or their agents.
5. As a material inducement to Employer and Parent to enter into this Agreement, Employee hereby irrevocably
releases Employer and Parent and each of the owners, stockholders, predecessors, successors, directors, officers, employees, representatives,
attorneys, affiliates (and agents, directors, officers, employees, representatives and attorneys of such affiliates) of Employer and Parent
and all persons acting by, through, under or in concert with them (collectively, the “Releasees”), from any and all
charges, claims, liabilities, agreements, damages, causes of action, suits, costs, losses, debts and expenses (including attorneys’
fees and costs actually incurred) of any nature whatsoever, known or unknown, including, but not limited to, rights arising out of alleged
violations of any contracts, express or implied, any covenant of good faith and fair dealing, express or implied, or any tort, or any
legal restrictions on Employer’s right to terminate employees, or any federal, state or other governmental statute, regulation,
or ordinance, including, without limitation: (1) Title VII of the Civil Rights Act of 1964, as amended by the Civil Rights Act of
1991 (race, color, religion, sex, and national origin discrimination); (2) the Employee Retirement Income Security Act (“ERISA”);
(3) 42 U.S.C. § 1981 (discrimination); (4) the Americans with Disabilities Act (disability discrimination); (5) the
Equal Pay Act; (6) the Age Discrimination in Employment Act; (7) the Older Workers Benefit Protection Act; (8) Executive
Order 11246 (race, color, religion, sex, and national origin discrimination); (9) Executive Order 11141 (age discrimination); (10) Section 503
of the Rehabilitation Act of 1973 (disability discrimination); (11) negligence; (12) negligent hiring and/or negligent retention;
(13) intentional or negligent infliction of emotional distress or outrage; (14) defamation; (15) interference with employment;
(16) wrongful discharge; (17) invasion of privacy; or (18) violation of any other legal or contractual duty arising under
the laws of the State of Maryland or the laws of the United States (“Claim” or “Claims”), which
Employee now has, or claims to have, or which Employee at any time heretofore had, or claimed to have, or which Employee at any time hereinafter
may have, or claim to have, against each or any of the Releasees, in each case as to acts or omissions by each or any of the Releasees
up to the time Employee signs this Agreement.
6. The release in the preceding paragraph of this Agreement does not apply to any rights, payments or benefits
after the effective date of the termination of this Agreement for (a) base salary pursuant to Section 2(a) of the Employment
Agreement accrued up to the effective date of termination, (b) any rights to, amounts due under or vesting of any unvested and outstanding
equity awards or grants made by Parent or any of its “Affiliates” (as defined in the Employment Agreement) to Employee, as
specified according to the terms and conditions of such awards or grants or pursuant to any plans or documents otherwise governing such
awards or grants, as modified by Section 2(c) of the Transition and Release Agreement, (c) pay for accrued but unused vacation
that Employer is legally obligated to pay Employee, if any, and only if Employer is so obligated, (d) any rights as provided under
the terms of any other employee benefit and compensation agreements or plans applicable to Employee, (e) expenses required to be
reimbursed pursuant to Section 2(d) of the Employment Agreement, (f) any rights Employee has under Section 2(h) of
the Employment Agreement (including without limitation any rights pursuant to that certain Directors and Officers Indemnification Agreement
dated February 21, 2018 between Parent and Employee), and (g) any rights the Employee may have (if any) to workers compensation
benefits.
Exhibit B - Page 2
7. Employee promises that he will not make statements disparaging to any of the Releasees other than truthful
statements to any federal, state, or local governmental agencies regarding an investigation by or proceeding before such agency or a possible
violation of law or regulation. Employee agrees not to make any statements about any of the Releasees to the press (including without
limitation any newspaper, magazine, radio station or television station) or in any social or electronic media outlet without the prior
written consent of Employer. The obligations set forth in the two immediately preceding sentences will expire three years after the Effective
Date. Employee will also cooperate with Employer and its affiliates if Employer requests Employee’s testimony. To the extent practicable
and within the control of Employer, Employer will use reasonable efforts to schedule the timing of Employee’s participation in any
such witness activities in a reasonable manner to take into account Employee’s then current employment, and will pay the reasonable
documented out-of-pocket expenses that Employer pre-approves and that Employee incurs for travel required by Employer with respect to
those activities.
8. Except as set forth in this Section, Employee agrees not to disclose the existence or terms of this Agreement
to anyone. However, Employee may disclose it to a member of his immediate family or legal or financial advisors if necessary and on the
condition that the family member or advisor similarly does not disclose these terms to anyone. Employee understands that he will be responsible
for any disclosure by a family member or advisor as if he had disclosed it himself. This restriction does not prohibit Employee’s
disclosure of this Agreement or its terms to the extent necessary during a legal action to enforce this Agreement or to the extent Employee
is legally compelled to make a disclosure. However, Employee will notify Employer promptly upon becoming aware of that legal necessity
and provide it with reasonable details of that legal necessity. Notwithstanding any other provision hereof, Employee may disclose the
existence and terms of this Agreement directly to any federal, state, or local governmental agencies to the extent Employee is communicating
with such agency regarding an investigation by or proceeding before such agency or a possible violation of law or regulation, and in the
event of such communication, Employee is not required to notify or seek approval or authorization from Employer of such communication.
In addition, Employee may disclose the existence or terms of this Agreement to the following employees of the Company: Chief Executive
Officer, President, Chief Financial Officer, Chief Accounting Officer, and Chief Legal Officer. The obligations set forth in this paragraph
will expire three years after the Effective Date.
Exhibit B - Page 3
9. Employee has not filed or caused to be filed any lawsuit, complaint or charge with respect to any Claim
he releases in this Agreement. Employee promises never to file or pursue a lawsuit, complaint or charge based on any Claim released by
this Agreement, except that Employee may participate in an investigation or proceeding conducted by an agency of the United States Government
or of any state. Notwithstanding the foregoing, Employee is not prohibited from filing a charge with the Equal Employment Opportunity
Commission but expressly waives his right to personal recovery as a result of such charge. Employee also has not assigned or transferred
any claim he is releasing, nor has he purported to do so. Notwithstanding any other provision hereof, Employee is not prohibited from
initiating or participating in an investigation or proceeding conducted by any federal, state, or local governmental agencies regarding
a possible violation of law or regulation or, other than in connection with a charge filed with the Equal Employment Opportunity Commission,
recovering a monetary award for initiating or participating in any such investigation or proceeding.
10. Employer, Parent and Employee agree that the terms of this Agreement shall be final and binding and that
this Agreement shall be interpreted, enforced and governed under the laws of the State of Maryland. The provisions of this Agreement can
be severed, and if any part of this Agreement is found to be unenforceable, the remainder of this Agreement will continue to be valid
and effective.
11. This Agreement sets forth the entire agreement among Employer, Parent and Employee and fully supersedes
any and all prior agreements or understandings, written and/or oral, between Employer and Employee pertaining to the subject matter of
this Agreement.
12. Employee is solely responsible for the payment of any fees incurred as the result of an attorney reviewing
this agreement on behalf of Employee. In any litigation concerning the validity or enforceability of this contract or in any litigation
to enforce the provisions of this contract, the prevailing party shall be entitled to recover reasonable attorneys’ fees and costs,
including court costs and expert witness fees and costs.
Employee’s signature below indicates Employee’s
understanding and agreement with all of the terms in this Agreement.
Employee should take this Agreement home and carefully
consider all of its provisions before signing it. Employee has been provided at least twenty-one (21) days to decide whether Employee
wants to accept and sign this Agreement. Also, if Employee signs this Agreement, Employee will then have an additional seven (7) days
in which to revoke Employee’s acceptance of this Agreement after Employee has signed it. This Agreement will not be effective
or enforceable, nor will any consideration be paid, until after the seven (7) day revocation period has expired. Again, Employee
is free and encouraged to discuss the contents and advisability of signing this Agreement with an attorney of Employee’s choosing.
Employee
should read carefully. This agreement includes a release of all known and unknown claims through the effective date. Employee is strongly
advised to consult with an attorney before executing this document.
Exhibit B - Page 4
IN WITNESS WHEREOF, Parent,
Employer and Employee have executed this Agreement effective as of the date first written above.
OMEGA HEALTHCARE INVESTORS, INC.
By:
C. Taylor Pickett, Chief Executive Officer
OHI ASSET MANAGEMENT LLC
By:
C. Taylor Pickett, Chief Executive Officer
EMPLOYEE
By:
Robert O. Stephenson
Date Signed
EX-10.4 — EXHIBIT 10.4
EX-10.4
Filename: tm2615007d1_ex10-4.htm · Sequence: 5
Exhibit 10.4
Execution Version
CONSULTING AGREEMENT
This Consulting Agreement
(this “Agreement”) is entered as of May 19, 2026 to be effective as of August 2, 2026, by and between Omega
Healthcare Investors, Inc. (hereinafter “Omega” or the “Company”) and Robert O. Stephenson
(hereinafter “Consultant”).
RECITALS
WHEREAS,
until August 1, 2026, Consultant was an officer of Omega, as well as an officer and director of subsidiaries of Omega (collectively,
the “Omega Companies”);
WHEREAS,
Consultant has expertise in the area of Omega’s business and is willing to provide consulting services to Omega as set
forth herein; and
WHEREAS,
Omega is willing and desires to engage Consultant as an independent contractor, during the Term (as defined below), on the terms and conditions
set forth herein.
NOW,
THEREFORE, in consideration of the foregoing and of the mutual promises set forth herein, and intending to be legally bound,
the parties hereto agree as follows:
AGREEMENT
1.
Term; Termination; Rights on Termination.
(a)
This Agreement will commence on August 2,
2026, and unless modified by the mutual written agreement of the parties, shall continue until and through August 1, 2027 (as it
may be extended, the “Term”), which shall be subject to extension by the Company (exercisable in the Company’s
sole discretion) until and through February 1, 2028 to the extent the Company provides written notice to the Executive on or before
August 1, 2027. This Agreement may be terminated at any time, with or without cause, by either party with ten (10) days written
notice to the other party, and will also terminate if Consultant dies during the Term. The effectiveness of this Agreement is contingent
upon Consultant signing on August 2, 2026, and returning on August 2, 2026 that certain Release Agreement and not revoking
the Release Agreement within the revocation period provided therein.
Page 1
(b)
If Omega terminates this Agreement during the Term, other than for Consultant’s willful failure or gross negligence in performing the consulting services described on Schedule A hereof (the “Services”) or due to a material breach of that certain Transition and Release Agreement dated May 19, 2026 (the “Transition Agreement”) or another agreement described therein, Consultant shall receive from Omega, the monthly Consulting Fee (defined below) then in effect for whatever time period is remaining under the Term. If Omega terminates this Agreement due to Consultant’s willful failure or gross negligence in performing the Services or due to a material breach of the Transition Agreement or another agreement described therein or Consultant terminates this Agreement during the Term or dies during the Term, the Company shall pay Consultant only so much of the monthly Consulting Fee as have accrued to the date of termination of this Agreement.
2.
Compensation.
In consideration of the Services that may be performed by Consultant, Omega agrees to pay Consultant $12,000 per month during the Term as a retainer for Consultant’s services for Services of up to twenty (20) hours per month, subject to the maximum number of hours of services to be provided as described in Section 3(b) below, with monthly payments being made on or before the last business day of the month following provision of the Services during the Term of this Agreement (“Consulting Fee”). Should Consultant exceed 20 hours per month in provision of the Services, the Chief Executive Officer and Consultant shall mutually agree on any additional fee payable, if any. The Company may withhold from any amounts payable with respect to this Agreement such federal, state, local and other taxes as may be required to be withheld, if any, pursuant to any applicable law or regulation. As Consultant is not an employee of any of the Omega Companies, Consultant shall not be permitted to participate in any benefit plans of any of the Omega Companies, except for any right he has to participate in group health plans pursuant to COBRA as a result of a termination of employment.
3.
Terms and Scope of Services.
(a)
This Agreement shall control and govern all work performed by Consultant. No subsequent variance from, amendment to or modification of this Agreement shall be binding upon the Omega Companies unless it is in writing, expressly provides that it is intended as a variance, amendment or modification and is executed by a fully authorized representative of the Omega Companies.
(b)
The scope of services to be provided hereunder is set forth in Schedule A hereto and as further modified and amended under subsequent written agreements between the parties. It is understood that the number of hours of services to be provided hereunder per month are expected over the Term not to exceed twenty percent (20%) of the time worked by Consultant per month for the Omega Companies averaged over the thirty-six month period before the first day of the Term.
(c)
All travel and out-of-pocket expenses incurred by Consultant for the benefit of the Omega Companies and in the performance of this agreement that are approved by the Company, shall be reimbursed by the Company within ten (10) business days following presentation of valid expense receipts.
Page 2
(d)
All payments to Consultant hereunder will be reported on Form 1099, and Consultant agrees to accept exclusive liability for the payment of all taxes, contributions for unemployment insurance, old age and survivor’s insurance or annuities, which are based on the fees and expense reimbursements paid to Consultant; and Consultant agrees to reimburse Omega for any of the aforesaid taxes or contributions which by law Omega may be required to pay because of Consultant’s failure to pay the same.
(e)
The level of Consultant’s services under this Agreement is intended to result in a “separation from service” (as defined under Section 409A of the Internal Revenue Code) occurring on August 1, 2026. Consultant acknowledges that the Company makes no warranties as to any tax consequences regarding payment of the Consulting Fee, and Consultant shall solely be responsible for payment of his own taxes.
(f)
Consultant, as an independent contractor, shall personally perform the services rendered under this Agreement and may not subcontract or delegate his duties to any other party. It is specifically understood and agreed that the manner and means of performing the services required under this Agreement shall be at the sole discretion of the Consultant through use of his independent judgment. Subject to Section 3(b), Consultant shall devote sufficient business time and efforts to the performance of services for the Company to complete the services within the time frames for completion established by the Company. Consultant shall use Consultant’s best efforts in such endeavors. Consultant shall also perform Consultant’s services with a level of care, skill, and diligence that a prudent professional acting in a like capacity and familiar with such matters would use.
(g)
Consultant shall have no authority to bind the
Omega Companies or any of its officers or employees to any agreement or to make managerial or Consultant decisions that are binding on
the Omega Companies. Consultant shall not be subject to the supervision, direction or control of the Omega Companies as to the particular
means or methods of performing his services. However, the Omega Companies shall retain the right to review and inspect at any time any
part of the work performed by Consultant to assure compliance with appropriate standards and specifications.
(h)
Upon request or when Consultant’s relationship with the Company terminates, Consultant will immediately deliver to the Company all copies of any and all materials and writings received from, created for, or belonging to the Company including, but not limited to, those which relate to or contain proprietary or confidential information, consistent with the requirements of the Intellectual Property Agreement.
Page 3
4.
Indemnification. The Company will indemnify Consultant for expenses actually and reasonably incurred that directly result from any claims made against Consultant arising out of any actions by Consultant that are within the scope of services, and consistent with the standards of performance, required under this Agreement, except to the extent that the Consultant’s actions were dishonest, were in bad faith, were opposed to the interests of the Company, involved an improper personal benefit to Consultant, involved criminal conduct by Consultant or were grossly negligent; provided, however, as a condition of indemnification, Consultant must promptly notify the Company of each claim that may give rise to indemnification hereunder and all relevant facts of which Consultant is aware and, unless the Company has a conflict of interest, the Consultant must allow the Company to assume the defense of the claim.
5.
Entire Agreement. This Agreement contains the entire understanding and agreement between the parties hereto with respect to its subject matter and supersedes any prior or contemporaneous written or oral agreements, representations or warranties between them respecting the subject matter hereof, other than the Transition and Release Agreement entered into between Consultant and Omega.
6.
Amendment. This Agreement may be amended only by a writing signed by Consultant and by a duly authorized officer of Omega.
7.
Remedy for Breach. Should either Consultant or Omega resort to legal proceedings to enforce this Agreement, the prevailing party in such legal proceeding shall be awarded, in addition to such other relief as may be granted, attorneys’ fees and costs incurred in connection with such proceeding.
8.
Governing
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The
parties agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy
arising under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The parties
consent to the jurisdiction of such courts.
9.
Duplicate.
This Agreement may be executed in duplicate originals and is not effective unless signed by both parties.
IN WITNESS WHEREOF,
Omega and Consultant have executed this Agreement effective as of the date first written above.
Consultant
Omega Healthcare Investors, Inc.
By:
/s/ Robert O. Stephenson
By
/s/ C. Taylor Pickett
Robert O. Stephenson
C. Taylor Pickett, Chief Executive Officer
Page 4
SCHEDULE A
SCOPE OF SERVICES
Consultant shall render such transitional support
services and perform such individual projects as may be requested by the Chief Executive Officer of Omega from time to time during the
Term (the “Services”). All services rendered and performance thereof shall be at the direction of the Chief Executive
Officer of Omega.
Schedule A – Page 1
EX-99.1 — EXHIBIT 99.1
EX-99.1
Filename: tm2615007d1_ex99-1.htm · Sequence: 6
Exhibit 99.1
303 International Circle P: 410.427.1700
Suite 200
Hunt Valley, MD 21030
PRESS RELEASE – FOR IMMEDIATE RELEASE
OMEGA ANNOUNCES ITS PLANNED LEADERSHIP TRANSITION
Taylor Pickett, CEO, to retire October 1st;
stepping down from Board of Directors
Matthew Gourmand, President, promoted to CEO;
to join Board
Bob Stephenson, CFO, to retire August 1st
Neal Ballew, CAO, promoted to CFO
HUNT VALLEY,
MARYLAND – May 21, 2026 – Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or
“Omega”) today announced that Matthew Gourmand, President of Omega, will become the Company’s Chief Executive Officer
in conjunction with the planned retirement of Taylor Pickett effective October 1, 2026. Mr. Pickett will step down from the
Board of Directors upon his retirement, and the Board of Directors intends to appoint Mr. Gourmand to the Board, effective on that
date.
Omega also announced the planned retirement of Bob Stephenson as the
Company’s Chief Financial Officer effective August 1, 2026, with Neal Ballew, currently Omega’s Chief Accounting Officer
of six years, succeeding Mr. Stephenson in that role.
Craig Callen, Chair of the Board of Directors, stated, “I am
excited to announce the next generation leadership of Omega, with Matthew and Neal stepping up into the CEO and CFO roles as the culmination
of a carefully managed, multi-year succession plan. The Board has been developing this plan over an extended period and believes it will
lead to Omega’s continued success.”
Mr. Callen continued regarding Mr. Gourmand, “We have
had the opportunity to see Matthew evolve in various roles and, with his deep investing experience and a leadership style rooted in collaboration
and innovation, he is well-prepared to lead the Company in its next phase of growth.”
Mr. Pickett stated, “Having worked with Matthew for the
past eight years, I believe he is the right person to take the Company forward. With a highly experienced and driven team to support
him, I am confident that Omega is well-positioned to continue to increase shareholder value.”
Mr. Pickett’s retirement marks the end of a remarkable 25
years as Omega’s CEO, during which Omega has achieved a total shareholder return of over 10,000%, the highest return of all publicly
traded REITs over that period. Its portfolio of predominantly senior care assets grew from 258 to 1,124 as of the past quarter, and its
market capitalization increased from approximately $60 million to over $15 billion today.
Mr. Callen commented, “Throughout Taylor’s 25 years
as CEO of Omega, his strategic vision and strong leadership have created an industry-leading company well-positioned to capture current
and future demographic trends. Taylor created a strong culture based on achievement, prudent capital allocation and development of future
executives. That team now stands ready to build upon this success.”
Mr. Stephenson also has had a remarkable career at Omega, overseeing
significant growth in the capital base and the establishment of investment grade credit ratings, reflecting strong balance sheet management.
Mr. Pickett stated, “During Bob’s 25-year tenure as
CFO, his financial management has been exceptional. He inherited a deeply challenged balance sheet, which he has methodically and judiciously
strengthened over the years. He leaves Omega as an investment-grade credit, with a well-laddered maturity schedule, and leverage near
all-time lows, with Neal very well-trained and ready to step up. I would like to thank Bob for being such a great partner to me in the
leadership of Omega.”
Mr. Callen continued, “We thank both Taylor and Bob for
their unwavering service to shareholders and wish each of them a long and well-deserved retirement.”
Mr. Pickett said, “It has been an honor and a privilege
to lead Omega since 2001. I am proud of our team’s many accomplishments, and I am grateful to my colleagues, our Board of Directors,
our operating partners, and all those who have contributed to Omega’s success during my tenure.”
Mr. Stephenson commented, “It has been the highlight of
my professional life to be part of the Omega leadership team and oversee the financial evolution and growth of the Company from its early
day struggles to its present position as a large scale, financially sound industry leader.”
Mr. Stephenson continued, “I have worked very closely with
Neal since he joined Omega. He is highly skilled, bright, and talented, and will provide great continuity. As we start a multi-decade
tailwind from the aging of the baby boomers, and with Matthew and Neal ready to step into their new roles, I feel as confident about
the future of Omega as I feel proud of the past.”
Reflecting on his impending new role, Mr. Gourmand noted, “I
am excited to serve as Omega’s next CEO and lead this exceptional team in its next chapter. I am grateful for the trust that the
Board has placed in me, and I will work tirelessly to repay that trust. I want to thank Taylor and Bob for growing and shaping Omega into
what it is today, as well as all their mentorship and counsel to prepare me for this next step. They will be deeply missed, but the culture
of excellence and an unwavering focus on creating shareholder value will continue.”
Both Mr. Pickett and Mr. Stephenson have agreed to remain
in consulting roles after their retirements, being available to the Company as requested from time to time during their consulting periods.
* * * * * *
Omega is a real estate investment trust (“REIT”)
that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of
assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions
within the U.S., as well as in the U.K.
FOR FURTHER INFORMATION, CONTACT
Andrew Dorsey, VP, Corporate Strategy &
Investor Relations
or
David Griffin, Sr. Director, Corporate Strategy &
Investor Relations at (410) 427-1705
Forward-Looking Statements and Cautionary
Language
This press release includes forward-looking
statements within the meaning of the federal securities laws. All statements regarding Omega’s or its tenants’, operators’,
borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends
and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating
metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth
opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and
statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,”
“expect,” “intend,” “may,” “could,” “should,” “will” and other
similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may
differ from Omega's expectations.
Omega’s actual results may differ materially
from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties
relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory
matters, occupancy levels and quality of care, including the management of infectious diseases; (ii) our operators’ ability
to manage industry challenges, including staffing shortages, which may impact certain regions more acutely, increased costs, and the sufficiency
of governmental reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other
changes in the healthcare sector, including changes to Medicaid and Medicare reimbursements, the potential impact of recent changes to
state Medicaid funding levels as well as legislative and regulatory initiatives related to establishing minimum staffing requirements
for skilled nursing facilities (“SNFs”) that may further exacerbate labor and occupancy challenges for Omega’s operators;
(iv) the ability of any of Omega’s operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega’s
mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain
security deposits for the debtor’s obligations, and other costs and uncertainties associated with operator bankruptcies; (v) changes
in tax laws and regulations affecting REITs, including as the result of any federal or state policy changes driven by the current focus
on capital providers to the healthcare industry; (vi) Omega’s ability to re-lease, otherwise transition or sell underperforming
assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy
the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and assisted living facility (“ALF”)
markets or local real estate conditions; (vii) the availability and cost of capital to Omega; (viii) changes in Omega’s
credit ratings and the ratings of its debt securities; (ix) competition in the financing of healthcare facilities; (x) competition
in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs;
(xi) changes in the financial position of Omega’s operators; (xii) the effect of economic, regulatory and market conditions
generally, and particularly in the healthcare industry in the U.S. and in other jurisdictions where we conduct business, including the
U.K.; (xiii) changes in interest rates and foreign currency exchange rates and the impact of inflation and changes in global tariffs
and international trade disputes; (xiv) the timing, amount and yield of any additional investments; (xv) Omega’s ability
to maintain its status as a REIT; (xvi) operational risks associated with our investments in healthcare operating companies, including
senior housing properties managed through structures authorized by the REIT Investment Diversification and Empowerment Act of 2007 (commonly
referred to as “RIDEA”); (xvii) the use of, or inability to use, artificial intelligence by us, our operators, managers,
vendors and investors; (xviii) the effect of other factors affecting our business or the businesses of Omega’s operators that
are beyond Omega’s or operators’ control, including natural disasters, public health crises or pandemics, cyber threats and
governmental action, particularly in the healthcare industry, and (xix) other factors identified in Omega’s filings with the
Securities and Exchange Commission. Statements regarding future events and developments and Omega’s future performance, as well
as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.
We caution you that the foregoing list of important factors may
not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements.
All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly
update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required
by law.
GRAPHIC
GRAPHIC
Filename: tm2615007d1_ex99-1img001.jpg · Sequence: 10
Binary file (25698 bytes)
Download tm2615007d1_ex99-1img001.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 12
v3.26.1
Cover
May 19, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 19, 2026
Entity File Number
1-11316
Entity Registrant Name
OMEGA HEALTHCARE INVESTORS, INC.
Entity Central Index Key
0000888491
Entity Tax Identification Number
38-3041398
Entity Incorporation, State or Country Code
MD
Entity Address, Address Line One
303 International Circle
Entity Address, Address Line Two
Suite 200
Entity Address, City or Town
Hunt Valley
Entity Address, State or Province
MD
Entity Address, Postal Zip Code
21030
City Area Code
410
Local Phone Number
427-1700
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, $.10 par value
Trading Symbol
OHI
Security Exchange Name
NYSE
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration